rfhg_138456.1

Basic information about the TSS

---

TSS ID: rfhg_138456.1 Species: human Chr: chr11		Start: 64246163 End: 64246182 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000392210.6:-11 GeneID: 26472 HGNC/MGI_ID: HGNC:9057 UniProt_ID: F5GXC4 Nearer transcript ids and distances: ENST00000542235.1:347 AF318364:347 BT009914:-491 EU832608:-496 EU832678:-496 view more...

Gene_name: protein phosphatase 1 regulatory inhibitor subunit 14B Gene_symbol: PPP1R14B Gene_synonyms: PHI-1 PNG SOM172 Gene_source: HGNC:9057

TATA-Box annotation

---

Distance to TSS:	306
Nearest PromoterID:	NR_135087
Entrez ID:	105369340
Nearest Unigene:	Hs.697228
Nearest Refseq:	NR_135086
Nearest Ensembl:	ENSG00000256940
Gene Name:	protein phosphatase 1 regulatory inhibitor subunit 14B
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.052632
GC%:	0.650000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PPP1R14B p2@PPP1R14B p3@PPP1R14B p4@PPP1R14B p5@PPP1R14B p6@PPP1R14B p7@PPP1R14B p8@PPP1R14B
Sample		p1@PPP1R14B	p2@PPP1R14B	p3@PPP1R14B	p4@PPP1R14B	p5@PPP1R14B	p6@PPP1R14B	p7@PPP1R14B	p8@PPP1R14B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	54.54	8.18	3.12	0.00	0.19	0.00	0.00	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	58.87	9.10	2.83	0.00	0.40	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	49.58	6.75	3.09	0.00	1.16	0.00	0.00	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	54.06	6.24	2.08	0.00	0.00	0.00	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	58.27	10.12	3.60	0.00	0.00	0.00	0.00	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	49.23	6.98	2.71	0.00	0.00	0.00	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	72.56	8.28	2.61	0.00	0.65	0.44	0.00	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	56.44	8.48	2.66	0.00	0.00	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.66	10.04	2.99	0.00	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	31.30	8.69	1.16	0.00	1.74	0.00	0.58	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.91	8.08	0.40	0.40	0.00	0.00	0.40	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	37.00	5.29	0.00	0.00	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.76	7.09	4.51	2.90	3.22	0.48	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.05	6.16	2.71	2.86	3.01	0.30	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.08	5.93	3.95	3.95	3.51	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.36	6.79	4.02	2.77	2.26	1.26	0.75	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.53	4.37	3.93	2.84	2.62	0.66	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.45	6.33	1.69	4.22	2.95	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	4.80	0.53	1.07	4.27	0.53	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	22.72	6.92	3.01	3.31	3.76	1.20	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	22.19	6.68	3.61	4.01	4.54	0.53	1.07	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.07	5.01	3.80	4.49	5.01	1.55	1.21	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	19.65	6.46	3.10	3.23	3.62	0.65	0.65	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.81	7.28	5.10	2.43	3.15	1.46	1.21	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.19	7.48	3.61	4.13	2.32	1.03	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.57	6.01	1.90	5.70	4.75	1.58	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	6.59	2.20	7.69	2.75	0.55	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.75	8.02	4.01	4.48	2.59	0.94	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.61	9.37	4.52	6.30	4.52	0.81	1.45	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	26.24	7.06	3.62	4.71	2.35	0.72	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	17.58	7.33	5.02	3.77	2.93	1.47	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.83	6.64	4.49	3.52	1.95	1.17	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.78	7.60	5.06	4.01	3.17	1.06	1.06	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.12	6.93	1.48	3.63	4.12	2.14	2.14	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	22.06	6.17	3.74	4.30	3.55	1.12	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.19	7.66	6.32	5.75	2.68	0.57	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.48	7.15	5.52	3.27	2.66	0.82	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.36	10.07	4.43	4.23	2.42	1.81	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.40	7.29	4.59	4.86	2.97	0.81	1.62	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.72	6.24	4.08	4.08	4.32	0.72	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.23	7.06	4.94	2.59	1.88	0.71	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.84	5.42	2.05	5.86	1.76	0.88	1.61	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.40	6.12	4.01	3.59	2.32	0.84	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.80	7.69	4.90	4.02	2.10	1.57	0.87	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.67	6.02	4.82	5.42	3.61	1.20	1.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.54	5.82	5.35	5.82	3.72	1.63	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.11	7.68	5.28	4.80	3.12	1.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.31	8.64	6.26	6.26	3.58	1.79	1.79	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	19.63	8.38	5.98	6.46	2.39	1.20	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.44	6.27	5.26	7.68	1.62	0.61	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.30	5.33	2.05	9.63	2.05	1.02	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.57	8.23	2.45	9.56	2.67	1.33	1.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.77	7.81	1.77	5.32	0.71	0.71	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.88	7.95	1.66	9.61	2.32	1.66	2.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	3.36	0.00	11.75	6.71	0.84	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.45	5.05	0.92	7.35	3.67	1.38	2.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.66	6.16	4.21	7.13	1.62	1.62	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.45	8.35	4.82	6.42	2.25	0.64	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.86	7.54	1.89	12.89	1.57	2.51	2.83	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	9.87	2.82	8.46	1.41	3.53	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.26	3.93	4.49	7.29	1.12	1.12	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	7.96	1.59	19.90	3.18	0.80	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	14.61	4.76	3.40	14.61	0.68	1.70	2.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.87	5.52	5.20	12.35	0.97	0.97	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.20	6.74	6.39	8.87	1.42	1.06	1.77	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	15.79	0.00	0.00	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.53	6.34	2.44	4.88	1.95	0.49	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.89	4.46	4.46	3.47	1.98	1.49	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	4.69	1.88	7.04	0.47	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.90	5.30	1.32	4.97	1.66	1.32	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.68	6.50	4.02	3.71	2.47	0.62	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.51	7.95	5.50	2.14	1.22	1.22	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	25.34	6.18	1.74	0.48	0.79	0.48	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	24.87	7.06	0.32	0.48	1.44	0.00	0.00	0.80
Adipocyte - omental, donor1	11473-119C6	20.10	4.58	1.15	0.25	0.38	0.00	0.13	0.38
Adipocyte - omental, donor2	11474-119C7	11.96	4.48	0.75	2.24	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	11.72	4.35	1.67	0.00	0.67	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	13.40	8.93	0.00	0.00	0.00	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	29.69	3.30	0.00	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	30.26	5.87	0.45	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.24	6.43	1.04	0.17	0.00	0.00	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	23.08	11.15	3.32	0.59	0.20	0.20	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	14.67	6.69	2.06	0.00	0.26	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	27.32	6.13	1.95	0.28	0.56	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	18.22	18.22	0.00	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	27.99	10.86	3.94	0.16	0.56	0.08	0.08	3.46
Adipocyte differentiation, day08, donor2	13023-139D8	17.11	10.65	0.65	0.00	0.32	0.00	0.32	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	7.46	1.60	0.00	0.53	0.00	0.53	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	15.58	13.91	0.56	0.00	0.56	0.00	0.56	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	17.05	4.57	0.83	0.42	0.42	0.00	0.00	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	13.81	6.78	0.75	0.00	0.75	0.50	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	19.31	7.53	0.98	0.00	0.00	0.00	0.00	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	17.66	6.39	0.91	0.00	0.00	0.00	0.00	2.44
Alveolar Epithelial Cells, donor1	11510-119G7	65.19	7.73	5.08	1.99	0.66	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	74.94	19.00	5.74	1.43	0.72	2.51	0.72	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	3.59	4.79	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.92	7.74	3.06	0.00	0.72	0.90	0.90	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	31.80	11.71	0.00	0.00	1.67	1.67	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	36.98	7.60	2.88	0.21	0.62	0.82	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	17.62	3.55	1.72	1.37	1.14	0.23	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	12.74	4.90	0.49	2.94	0.49	0.73	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.91	6.74	1.80	1.35	0.00	0.45	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.05	3.91	2.60	1.30	0.87	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	2.14	0.00	4.28	4.28	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.21	7.17	1.49	1.20	1.79	0.60	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	6.32	2.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	30.36	2.64	0.66	2.64	0.66	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.69	4.55	1.30	1.30	0.32	0.65	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.27	6.80	0.97	0.97	1.94	0.00	0.49	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.32	4.75	2.97	1.19	0.59	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.99	4.14	3.01	1.13	1.88	1.13	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	5.81	3.63	1.45	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	11.28	2.51	1.25	2.51	1.25	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	32.95	4.61	3.13	2.14	0.82	0.49	0.16	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	2.73	1.36	0.00	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.01	6.03	2.11	2.26	1.21	0.15	0.45	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.36	3.75	2.14	0.54	2.68	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	33.06	5.29	2.46	1.70	1.89	0.57	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.54	3.74	1.87	2.14	1.87	0.53	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	9.75	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.69	4.81	1.99	1.99	1.00	0.17	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	4.80	1.20	8.41	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.56	8.40	1.89	1.54	0.69	0.69	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	3.88	1.46	0.49	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	29.60	5.69	2.66	0.76	1.52	1.14	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	39.98	7.27	0.00	6.06	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	6.27	3.99	1.14	2.28	1.71	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.65	5.13	2.57	2.14	1.28	0.86	0.21	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.52	3.36	2.06	3.10	1.55	0.52	0.00	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	25.34	5.16	2.35	0.47	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	32.15	4.82	0.96	1.29	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.97	4.28	0.00	1.43	1.43	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	4.09	5.85	0.58	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	27.10	4.82	1.81	2.41	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	29.70	7.13	3.56	4.75	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.41	4.58	3.05	0.51	0.51	1.02	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	34.38	5.09	2.04	1.53	2.29	0.51	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.69	3.18	1.27	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	26.32	6.90	3.45	2.16	0.86	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.25	6.14	1.48	2.33	0.85	0.42	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	31.61	5.51	1.74	1.16	1.16	0.58	1.16	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	5.67	1.89	0.00	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.80	6.44	2.20	1.36	1.36	0.34	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	4.63	0.00	0.00	0.00	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	4.23	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	32.81	5.57	3.00	0.64	1.07	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.87	5.41	1.20	1.20	1.20	0.00	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	18.95	5.83	1.46	2.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.95	4.37	1.84	2.53	1.15	0.00	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	5.10	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	34.83	5.59	1.78	2.29	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	28.08	6.81	1.65	2.68	0.41	0.41	0.62	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	21.73	6.43	2.14	0.92	1.22	0.00	0.00	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.03	7.17	2.39	0.48	0.96	0.48	0.00	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	4.43	1.11	1.11	0.44	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	4.58	0.00	3.05	0.00	1.53	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	6.65	0.55	2.77	0.55	0.00	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.01	5.56	1.59	1.32	0.53	0.53	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	25.80	3.63	0.73	1.09	0.73	0.73	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	33.28	7.12	2.21	0.74	0.37	0.37	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	38.85	9.24	4.28	0.51	0.00	0.34	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	31.88	9.02	1.89	0.84	0.42	0.63	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	44.62	9.76	3.83	1.74	1.05	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	60.67	10.35	5.82	0.81	0.49	1.46	1.13	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	48.63	9.84	5.22	0.30	0.45	0.15	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.75	3.90	3.44	0.00	0.00	0.11	0.11	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	35.96	5.14	2.51	0.13	0.13	0.00	0.00	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	34.37	3.41	1.71	0.00	0.00	0.23	0.23	1.25
Basophils, donor1	12241-129G9	9.15	0.26	0.26	4.97	0.26	0.00	1.05	0.26
Basophils, donor2	12242-129H1	13.35	0.72	0.00	12.27	0.00	0.00	0.36	0.72
Basophils, donor3	12243-129H2	13.08	1.62	1.47	3.38	0.88	0.29	1.47	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	32.12	15.74	1.08	1.29	1.51	0.43	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	52.12	38.86	4.57	2.29	2.74	2.74	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	53.35	21.34	4.39	10.67	1.26	2.51	3.14	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	63.42	21.42	4.37	4.99	0.21	2.50	1.46	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	38.92	18.19	3.91	4.15	1.15	3.22	2.53	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	35.45	11.88	1.98	4.14	1.26	1.26	1.26	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	28.86	5.26	1.65	0.62	0.00	0.00	0.00	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	44.72	5.36	5.82	0.00	0.00	0.00	0.00	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	52.44	8.95	4.80	1.92	0.00	0.32	0.00	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	20.68	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.27	0.56	0.56	0.56	0.00	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	7.98	0.74	0.00	1.48	0.19	0.00	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	9.88	1.32	0.88	0.88	0.22	0.00	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	9.62	1.70	1.42	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.03	0.76	0.76	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.25	0.33	0.00	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.83	0.87	0.72	1.01	2.17	0.00	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	12.07	0.91	1.21	1.21	0.91	0.00	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	9.24	2.37	0.47	3.79	3.08	0.00	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.02	0.67	0.17	1.34	1.00	0.17	0.67	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.24	1.38	0.28	1.38	1.66	0.55	0.83	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.71	2.23	0.00	0.50	2.48	0.25	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.29	0.59	0.20	1.76	4.11	0.59	0.20	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.97	0.89	0.71	3.38	3.20	1.07	0.89	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	13.06	0.44	0.22	3.48	6.09	1.52	0.65	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.87	0.23	0.00	0.47	0.70	0.00	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.64	1.06	0.00	0.00	0.53	0.00	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	1.11	0.00	0.00	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.21	0.89	0.59	0.74	1.49	0.59	0.74	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.78	0.80	0.00	1.40	2.79	0.40	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.45	1.25	0.42	3.12	3.96	0.42	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.49	0.92	0.46	1.37	2.06	0.23	0.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.88	0.68	0.00	2.04	2.94	0.00	1.81	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4.80	0.44	0.00	0.87	0.87	0.44	0.87	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	0.54	0.00	1.88	1.88	0.00	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.34	1.74	0.70	2.27	4.54	0.70	0.52	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.94	0.84	0.42	1.68	4.63	1.26	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.23	0.37	0.00	0.73	2.57	0.55	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.28	1.06	0.00	2.82	4.23	0.70	1.76	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.39	0.88	0.00	0.00	1.32	0.44	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.81	1.74	0.52	2.62	8.02	0.35	0.70	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	0.37	0.37	3.35	9.29	0.00	1.12	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.70	0.65	0.00	1.08	7.54	0.86	1.08	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	1.23	0.00	0.41	1.23	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.17	0.70	0.00	0.93	2.32	0.00	1.62	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.94	0.70	0.00	1.62	1.39	0.46	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	13.30	1.31	1.31	0.00	0.22	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	9.47	1.85	0.46	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	9.96	0.65	1.08	0.00	0.22	0.00	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	11.83	0.78	1.25	0.00	0.16	0.00	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.46	1.40	0.35	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	8.47	0.67	0.22	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	19.39	1.28	0.77	0.26	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	10.98	0.44	0.44	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	12.21	1.89	0.21	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	4.06	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	11.53	0.68	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	1.04	2.07	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	25.59	0.00	0.00	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	19.30	1.61	2.14	0.00	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	15.44	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	3.14	1.57	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	3.95	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	8.22	0.82	0.82	1.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	6.53	2.18	0.00	0.73	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	6.56	1.01	0.00	0.50	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.12	7.68	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	15.58	5.99	0.40	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	14.06	0.00	1.00	3.01	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	14.05	2.81	0.56	6.74	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	39.45	6.76	3.38	3.38	0.00	0.00	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.10	8.79	4.28	4.96	0.00	0.00	0.00	1.35
CD4+ T Cells, donor1	11225-116C1	9.64	0.71	0.71	1.07	0.00	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	11.02	0.00	0.00	1.22	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	10.06	0.00	0.00	1.22	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.51	4.59	1.02	0.51	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	13.48	5.17	1.57	0.67	0.22	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	12.65	5.46	0.86	0.29	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	0.00	0.47	1.42	0.00	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	0.70	0.00	0.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	10.69	1.88	0.87	0.43	0.00	0.14	0.00	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	12.54	3.39	2.37	0.17	0.00	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.74	2.10	0.97	0.00	0.00	0.00	0.00	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	9.41	0.45	1.34	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.99	0.70	0.00	0.00	0.35	0.00	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.04	0.44	0.44	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	7.59	2.95	1.69	0.42	0.00	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	15.58	2.70	1.87	0.21	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.03	3.01	0.67	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	8.43	0.27	0.27	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.75	2.14	0.54	0.54	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	0.00	1.79	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	12.05	2.78	1.11	0.00	0.00	0.00	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	9.10	4.12	1.30	0.43	0.00	0.00	0.00	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.93	2.31	1.26	0.00	0.00	0.00	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	14.66	3.03	0.00	1.01	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	11.70	0.43	0.87	0.43	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.54	1.31	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	16.83	1.48	0.99	0.49	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	11.08	2.77	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	2.79	4.19	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	10.25	0.28	0.55	0.28	0.00	0.00	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	9.08	1.47	0.98	0.00	0.00	0.00	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	1.54	0.00	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.83	1.43	0.36	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	8.84	1.64	0.33	17.68	0.00	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	9.39	0.75	0.75	18.40	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	10.86	0.50	0.25	9.59	0.00	0.00	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.86	21.56	2.06	0.69	0.23	2.52	5.73	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.33	16.77	3.12	0.72	0.48	0.24	2.16	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.43	17.24	2.46	1.09	0.27	2.46	3.28	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.41	7.21	2.10	0.90	0.90	1.50	2.10	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.08	17.76	1.92	1.20	0.24	2.64	2.64	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	21.60	19.56	1.59	0.45	0.45	1.59	3.41	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.29	25.20	2.61	0.65	0.43	0.65	4.56	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.69	21.32	2.11	1.32	0.53	2.11	3.42	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.75	29.55	1.17	2.11	0.70	2.58	2.81	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.17	26.87	2.11	0.00	0.91	0.30	3.32	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.95	21.79	2.32	0.87	0.29	1.45	1.45	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.58	23.45	3.73	0.27	0.53	1.33	2.40	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	7.00	1.75	0.00	0.00	0.00	2.63	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	9.56	2.73	0.46	0.46	0.46	3.19	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	5.97	0.00	0.75	0.75	0.75	2.24	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.77	19.81	1.08	1.80	0.72	1.08	1.44	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.76	17.84	2.30	0.29	0.58	2.30	1.73	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.62	13.20	2.59	1.18	0.00	2.36	4.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.60	25.04	3.17	0.95	0.00	1.27	4.75	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.91	29.22	1.85	1.23	0.62	1.23	3.38	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.07	21.48	1.28	0.96	0.32	1.28	2.24	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.83	30.98	2.29	0.38	0.76	0.76	3.06	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	24.83	2.36	0.00	0.79	0.79	3.94	2.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.88	25.72	1.51	0.00	0.76	1.51	0.76	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.85	11.24	0.80	0.00	0.80	1.61	3.21	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.09	7.69	1.40	0.70	0.70	6.29	3.50	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	12.02	0.00	1.00	1.00	3.01	6.01	0.00
Cardiac Myocyte, donor1	11525-119I4	14.62	3.66	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	29.15	4.45	1.48	0.49	0.00	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	31.36	3.58	1.26	0.11	0.21	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	14.56	7.97	1.73	4.16	1.04	1.04	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	17.41	6.40	2.13	3.91	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	20.03	3.41	1.37	3.07	1.71	0.57	0.46	0.46
Chondrocyte - re diff, donor2	11339-117F7	40.29	12.53	4.48	4.48	1.79	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	43.68	9.71	3.24	2.02	1.62	1.21	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	37.98	5.39	3.79	0.00	0.46	0.11	0.11	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	57.72	4.70	3.42	1.07	0.43	0.21	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	43.54	4.96	3.45	0.44	1.24	0.35	0.35	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	9.54	1.28	0.92	0.18	0.09	0.00	0.00	0.28
Corneal Epithelial Cells, donor1	11526-119I5	44.57	16.69	3.73	1.10	1.10	0.44	0.66	0.22
Corneal Epithelial Cells, donor2	11606-120I4	27.30	28.44	2.28	2.28	4.55	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	51.38	22.24	2.30	2.30	1.28	0.51	2.05	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.32	10.73	0.33	0.00	0.17	0.00	0.17	1.98
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.98	8.20	0.63	0.00	0.32	0.00	0.32	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	3.45	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.92	9.40	1.30	0.11	0.32	0.00	0.11	1.51
Dendritic Cells - plasmacytoid, donor1	11228-116C4	65.60	11.96	4.44	107.62	0.00	0.00	0.34	6.49
Dendritic Cells - plasmacytoid, donor2	11309-117C4	93.36	15.67	5.22	154.73	0.00	0.00	3.92	9.79
Dendritic Cells - plasmacytoid, donor3	11385-118B8	51.78	19.36	2.42	126.79	0.48	0.00	0.48	8.71
Endothelial Cells - Aortic, donor0	11207-116A1	52.03	6.17	6.17	3.34	0.67	0.83	0.67	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	47.53	5.28	4.11	1.76	0.59	1.76	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	37.33	6.79	4.52	3.39	0.57	0.85	0.85	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	38.53	6.29	5.11	5.50	0.39	2.36	1.97	0.79
Endothelial Cells - Artery, donor1	11264-116G4	38.98	3.78	3.20	2.62	1.16	2.04	0.58	1.45
Endothelial Cells - Artery, donor2	11341-117F9	54.11	5.65	4.24	2.35	0.47	0.94	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	52.77	4.73	4.21	5.96	0.18	0.88	0.70	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	27.93	5.32	2.22	1.33	0.22	1.33	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.86	4.56	1.22	0.30	0.00	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	15.79	1.69	0.85	1.69	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	22.88	6.54	0.89	0.30	0.89	1.19	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	39.05	4.17	2.60	2.60	0.52	1.56	2.08	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	34.03	6.95	2.84	0.14	0.14	0.43	0.28	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	21.61	6.00	2.00	1.60	0.40	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	41.41	4.19	2.10	4.19	2.62	0.52	0.00	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	41.00	2.73	3.11	0.99	0.00	0.62	0.12	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.85	5.65	2.82	2.17	0.22	0.43	0.43	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	50.44	6.35	4.40	2.20	0.12	0.12	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	62.56	12.51	3.41	4.55	0.00	3.41	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	77.53	9.78	7.68	4.19	0.70	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	63.43	7.54	5.97	2.36	0.63	1.57	1.41	0.63
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	0.00	0.00	6.60	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.65	14.42	1.47	3.18	2.44	1.22	1.71	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	14.56	0.00	2.08	2.08	0.00	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.04	2.87	2.05	7.39	3.28	1.23	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.53	8.32	1.64	5.80	1.86	0.77	0.66	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	31.85	9.86	3.79	3.90	1.41	2.38	1.30	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	40.99	5.34	2.55	4.49	1.33	0.73	0.36	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.19	1.91	0.68	1.23	10.92	0.14	0.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	28.58	6.64	2.21	1.90	2.11	0.53	0.11	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.01	3.69	0.26	0.79	1.84	0.79	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	36.54	9.97	4.98	4.98	1.99	1.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	40.83	4.08	3.18	1.81	1.36	1.36	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	56.85	6.82	4.55	0.00	0.76	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	54.10	7.41	3.94	4.73	0.47	0.63	0.63	0.79
Fibroblast - Cardiac, donor4	11452-119A3	19.10	5.15	1.82	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	20.69	3.93	2.66	1.27	0.51	0.13	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	27.89	6.52	1.36	0.30	0.00	0.15	0.00	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.33	1.74	0.94	0.00	0.00	0.00	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.10	4.31	0.43	0.43	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	61.52	2.93	4.39	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	38.52	5.77	3.46	0.00	0.23	0.00	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	13.74	3.73	1.02	0.17	0.51	1.02	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	32.40	7.28	1.64	2.35	0.00	0.23	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	52.36	9.43	5.19	3.77	1.89	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	32.88	10.03	3.14	0.85	0.36	0.24	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	32.22	5.88	2.83	0.00	0.23	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	36.29	8.02	1.74	0.00	0.52	0.17	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	35.90	7.31	3.09	0.32	0.32	0.16	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	17.07	5.00	2.50	1.04	0.21	0.62	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.63	5.50	2.88	9.96	4.98	1.57	2.36	0.00
Fibroblast - Gingival, donor2	11318-117D4	44.41	11.07	4.35	1.32	0.92	0.53	0.79	0.26
Fibroblast - Gingival, donor3	11394-118C8	13.63	3.00	0.97	0.87	0.58	0.29	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	4.16	1.04	3.12	0.00	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.37	2.47	2.11	2.29	1.06	0.70	0.18	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.30	7.33	1.09	5.14	0.62	0.62	0.94	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.72	6.49	3.25	5.27	1.49	1.08	0.81	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	47.64	8.12	2.82	3.18	2.12	1.41	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.54	6.43	2.63	4.53	2.34	1.02	0.58	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	35.45	8.04	1.36	8.45	1.91	2.05	0.95	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	40.81	8.67	3.29	3.29	0.77	1.97	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	17.32	2.20	2.20	2.64	1.17	0.59	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	40.78	1.36	2.72	1.36	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	4.48	2.98	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	56.56	12.45	6.33	1.69	0.84	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	15.83	9.16	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	23.51	4.48	0.28	0.56	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	23.14	4.06	1.22	0.81	0.00	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	47.72	6.98	4.85	0.97	1.16	1.16	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	48.54	5.16	6.07	0.91	0.30	0.15	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.36	4.28	2.45	2.14	0.00	0.00	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	29.00	4.96	2.29	2.67	1.14	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.20	9.18	2.43	5.13	1.89	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	23.19	4.87	1.86	3.71	1.16	0.81	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	53.72	6.52	4.42	2.21	0.33	0.66	0.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.12	4.67	2.84	0.41	0.41	0.20	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.74	6.01	2.67	0.00	0.00	0.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.86	8.30	2.37	1.58	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.30	2.98	1.59	0.79	1.39	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.37	3.20	1.24	1.07	1.42	0.18	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.68	4.93	0.79	1.18	0.79	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	12.34	2.41	0.30	0.90	0.60	0.00	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	14.03	4.53	0.97	0.97	1.19	0.76	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.30	2.02	0.00	0.76	4.05	0.51	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	20.35	6.23	1.31	2.79	1.31	0.49	0.16	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.44	2.61	2.21	0.60	2.61	0.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	24.41	6.93	1.41	1.91	1.41	0.70	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.07	1.51	1.51	0.60	1.81	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	14.08	3.56	0.58	1.57	1.57	0.17	0.17	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	7.18	2.56	0.17	0.17	0.34	0.85	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.24	2.63	0.33	0.66	1.31	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	27.59	5.11	1.70	2.02	1.17	0.43	0.21	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	32.05	4.89	2.02	1.86	1.18	0.51	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.15	5.18	1.57	5.49	1.41	1.41	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	19.17	1.74	3.49	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	35.54	6.41	0.87	2.25	2.08	1.39	2.77	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.15	6.25	3.38	1.04	0.52	1.56	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	28.62	9.45	3.32	1.53	2.04	0.26	2.30	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	139.33	5.36	6.12	0.00	0.00	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	128.25	2.55	1.91	0.00	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	139.78	2.57	7.99	0.00	0.00	0.57	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.26	1.65	0.83	0.00	0.28	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	38.13	2.05	2.74	0.00	0.00	0.23	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	106.00	1.59	3.17	0.00	0.00	0.00	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	51.81	2.11	2.64	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	1.96	0.65	0.00	0.00	0.00	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	102.60	1.33	2.21	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	62.61	1.41	1.27	0.00	0.14	0.28	0.00	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	44.21	1.85	0.74	0.00	0.12	0.00	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	66.08	1.88	2.15	0.00	0.00	0.00	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.54	1.98	2.48	0.00	0.12	0.25	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	45.27	1.52	2.21	0.00	0.28	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.71	1.83	2.24	0.20	0.20	1.02	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	50.66	1.83	1.37	0.00	0.23	0.46	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.37	2.87	1.49	0.00	0.12	1.12	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	48.09	1.53	2.19	0.00	0.22	1.09	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.39	2.36	1.77	0.00	0.00	0.00	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.81	2.70	2.86	0.00	0.16	0.00	0.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.78	2.68	1.56	0.00	0.00	0.00	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	44.16	2.42	1.81	0.00	0.00	0.00	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.64	1.87	0.85	0.00	0.17	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	39.10	2.04	2.13	0.00	0.18	0.09	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.97	1.66	1.98	0.00	0.10	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.25	2.39	1.71	0.00	0.51	0.17	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	34.19	1.44	1.44	0.00	0.00	0.00	0.11	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.94	3.16	1.33	0.00	0.17	0.17	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.16	1.43	2.45	0.00	0.61	0.00	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	41.05	4.13	1.03	0.00	0.00	0.21	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.05	2.31	1.73	0.00	0.12	0.00	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.86	3.34	3.17	0.00	0.33	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.69	3.09	3.09	0.00	0.00	0.44	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.77	2.34	1.35	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.07	3.57	1.30	0.16	0.49	0.49	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.64	2.25	1.92	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.72	3.41	1.99	0.00	0.09	0.00	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	37.96	3.01	1.58	0.00	0.16	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.40	3.95	1.22	0.00	0.00	0.61	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.32	2.93	1.36	0.00	0.52	0.10	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	30.30	6.37	2.20	0.22	0.44	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.86	4.21	1.12	0.00	0.00	0.00	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	29.54	3.80	1.67	0.00	0.37	0.00	0.09	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.36	4.01	2.67	0.00	1.07	0.00	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.65	3.21	1.68	0.00	0.31	0.00	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.13	5.57	2.07	0.00	0.65	0.26	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	19.79	5.69	1.08	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.47	3.87	1.84	0.18	0.37	0.00	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	36.19	2.85	1.75	0.00	0.44	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	0.99	0.00	0.00	0.00	0.00	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.40	4.75	3.17	0.00	0.40	0.00	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.28	2.82	2.82	0.20	0.40	0.20	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	8.90	1.27	0.00	0.25	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	51.56	0.80	1.00	0.00	0.00	0.00	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	64.56	0.62	1.39	0.00	0.00	0.00	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	80.61	0.20	2.05	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	90.75	2.50	5.01	0.00	0.00	0.00	0.00	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	93.53	2.26	4.80	0.28	0.00	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	68.26	0.46	0.46	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	4.95	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	81.23	0.77	1.93	0.00	0.00	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	85.04	1.60	3.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	3.48	1.74	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	66.72	0.98	2.28	0.00	0.00	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.53	0.82	0.41	0.00	0.00	0.00	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	0.00	6.66	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	44.46	3.08	1.12	0.00	0.00	0.00	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	49.03	0.98	0.98	0.00	0.00	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	33.55	1.68	2.52	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.12	0.95	2.86	0.00	0.00	0.00	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	42.46	1.02	2.04	0.00	0.00	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	2.09	0.00	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	51.54	0.57	1.72	0.00	0.00	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	32.85	1.48	2.37	0.00	0.00	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	3.39	0.00	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.49	2.07	3.73	0.00	0.00	0.00	0.00	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.19	3.22	1.84	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	34.21	1.15	0.77	0.00	0.00	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	30.32	1.63	1.30	0.00	0.00	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.14	1.34	3.34	0.00	0.00	0.00	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	42.76	1.54	1.16	0.00	0.00	0.00	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.55	2.40	1.71	0.00	0.00	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	0.00	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	29.73	0.00	0.00	0.00	0.00	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	45.26	0.60	1.21	0.00	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.05	1.02	2.54	0.00	0.00	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	38.29	1.99	1.20	0.00	0.00	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.94	0.49	0.49	0.00	0.00	0.00	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	5.90	1.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	1.75	1.17	0.00	0.00	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.92	1.76	0.44	0.00	0.00	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.99	4.24	0.85	0.00	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.99	1.79	1.79	0.00	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.94	1.46	0.49	0.00	0.00	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	27.39	1.14	1.14	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.69	5.41	0.83	2.08	0.83	0.83	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	66.34	21.36	5.62	9.00	0.00	0.00	1.12	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.00	1.59	0.00	1.27	0.00	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.46	6.27	0.42	2.51	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	43.86	9.05	1.86	0.58	0.81	1.86	1.16	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	46.59	7.26	1.86	1.18	1.01	1.69	0.34	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	38.22	7.74	2.50	0.23	0.46	1.14	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	46.57	5.68	1.97	0.98	0.66	1.09	1.31	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	42.34	6.23	2.15	1.07	1.29	1.50	0.64	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	34.88	6.67	1.94	0.43	0.86	0.43	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	42.34	9.22	1.87	0.50	1.49	1.62	1.00	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	32.94	7.55	2.40	0.51	0.69	1.20	1.20	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	32.36	8.97	0.00	0.00	0.64	0.32	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	6.72	0.56	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	50.20	7.36	3.03	3.90	0.43	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	2.64	0.00	7.93	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	39.15	8.47	2.12	0.71	0.71	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	38.51	5.81	2.18	5.09	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	47.03	8.04	2.80	0.35	0.35	0.17	0.35	0.35
Hepatocyte, donor1	11523-119I2	4.84	0.00	0.00	0.00	0.00	0.00	0.00	3.63
Hepatocyte, donor2	11603-120I1	10.77	0.00	0.00	1.08	0.00	0.00	0.00	2.15
Hepatocyte, donor3	11684-122I1	4.91	0.61	2.45	0.00	0.61	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	33.94	4.57	1.31	0.00	0.00	0.00	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.93	2.80	1.57	0.00	0.17	0.00	0.00	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.28	2.33	2.88	0.41	0.96	0.00	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	47.07	5.54	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	52.56	10.01	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	12.81	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	13.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	48.73	6.50	0.00	0.00	0.00	0.00	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	10.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	7.26	0.00	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	62.20	9.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	44.35	8.87	3.33	0.00	0.00	0.00	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	38.42	7.56	5.04	0.00	0.00	0.00	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	10.83	0.00	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	36.82	5.17	0.65	0.00	0.00	0.00	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	9.66	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	51.34	8.96	2.44	0.00	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	43.24	6.72	1.68	0.00	0.42	0.00	0.00	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	36.97	8.84	0.80	0.00	0.80	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	55.40	10.16	3.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	50.04	10.86	2.83	0.00	0.00	0.00	0.00	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	61.67	7.26	2.72	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	51.65	9.69	4.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	50.82	13.98	3.81	0.00	0.00	0.00	0.00	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.80	7.65	1.28	0.00	0.00	0.00	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	10.94	3.65	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	36.42	9.28	1.43	0.00	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	9.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	31.79	8.03	1.23	0.00	0.00	0.00	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	5.27	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	43.81	8.34	2.78	0.00	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	11.07	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	61.60	3.24	6.48	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	7.85	1.74	0.00	0.00	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	9.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	38.40	11.73	2.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	8.31	0.00	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	0.00	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	6.44	0.92	0.00	0.00	0.00	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	6.05	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	2.11	1.06	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	26.52	6.20	1.22	0.90	0.98	0.82	0.49	0.24
Keratinocyte - epidermal, donor2	11349-117G8	45.09	9.37	2.34	2.93	0.59	1.76	3.51	0.00
Keratinocyte - epidermal, donor3	11421-118F8	44.39	8.90	3.03	5.21	1.23	2.18	3.22	0.09
Keratinocyte - oral, donor1	11251-116E9	42.68	11.92	3.41	1.25	0.34	0.34	0.34	0.00
Keratocytes, donor1	11527-119I6	46.07	19.25	3.09	1.72	1.38	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	41.01	9.37	2.34	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	11.46	6.52	0.79	0.00	0.00	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	8.79	4.40	19.78	2.20	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	44.23	4.31	2.16	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	38.41	5.31	2.42	0.23	0.69	0.35	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	22.91	2.83	1.41	0.50	0.30	0.30	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.36	4.03	2.73	1.19	0.24	0.24	0.36	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	25.67	3.63	3.07	1.12	0.28	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.41	2.83	1.57	0.79	0.16	0.63	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.90	5.38	2.15	1.61	1.61	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.65	5.04	0.63	0.95	0.00	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.34	2.26	3.02	1.94	0.22	0.54	0.65	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.57	3.69	2.87	1.64	0.41	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	31.86	5.31	2.53	1.26	0.25	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.41	2.82	1.69	1.13	0.42	0.28	0.42	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.17	3.16	2.77	1.98	0.40	0.79	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	26.37	3.49	1.94	0.39	0.19	0.58	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	30.92	2.41	2.96	1.85	0.74	0.74	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.87	4.18	2.09	1.74	0.70	1.39	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	25.52	4.77	1.67	0.72	0.72	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	24.31	2.75	2.06	1.10	0.00	0.69	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.09	5.24	4.62	1.23	0.00	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.30	4.36	1.87	0.62	0.31	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	22.32	3.48	3.11	2.01	0.00	0.55	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	27.97	3.95	1.97	0.66	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.38	6.15	2.64	0.29	0.00	0.59	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	27.88	5.48	1.74	1.24	1.00	0.75	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.31	9.21	2.42	1.45	0.00	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	24.51	3.77	2.69	1.08	0.00	0.27	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	21.04	1.82	3.18	1.36	0.15	0.76	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	5.70	2.59	0.00	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.55	5.65	3.35	1.05	0.00	1.05	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.02	3.01	1.65	0.90	0.15	0.45	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	3.44	3.44	1.38	0.00	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.33	3.39	2.82	0.38	0.00	1.32	0.38	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.52	3.07	2.86	1.06	0.11	0.32	0.42	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	2.42	1.94	0.97	0.48	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.50	2.65	2.32	0.00	0.33	0.99	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.29	2.97	1.98	1.36	0.12	0.50	0.87	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.95	3.70	2.22	1.48	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.67	3.46	2.22	0.99	0.00	0.25	0.49	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.75	4.26	2.61	1.51	0.55	0.55	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.16	5.79	1.61	0.32	0.00	0.00	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.65	4.26	1.83	0.61	0.00	0.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.25	2.94	2.24	1.82	0.42	0.28	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.96	6.40	1.78	1.07	0.71	0.36	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.30	2.42	2.42	0.97	0.00	0.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.96	3.27	1.71	1.09	0.16	0.47	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.36	5.01	3.94	2.86	0.72	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	23.52	3.27	2.61	0.00	0.00	0.00	0.65	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.84	4.24	2.35	1.41	0.00	0.47	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.10	3.59	3.09	1.49	0.25	0.62	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.50	4.10	2.31	1.02	0.00	0.77	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.59	5.07	1.49	2.09	0.00	0.00	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	9.06	0.00	0.00	0.00	2.27	2.27	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	6.14	1.53	0.00	0.77	0.00	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	8.16	0.74	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.58	7.19	0.00	0.42	0.85	0.42	0.85	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	8.44	4.92	0.70	0.00	2.11	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	44.83	6.54	0.93	0.00	0.93	0.93	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.58	8.24	1.03	1.03	0.00	0.52	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	2.38	1.19	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	27.60	6.79	2.49	0.45	0.23	0.00	0.45	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	22.68	4.94	0.87	1.16	0.29	0.87	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.91	6.75	0.45	0.45	0.45	0.45	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.05	5.83	1.49	1.08	0.68	0.95	0.41	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.14	7.19	0.51	1.54	0.00	0.51	0.00	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	22.94	9.17	2.12	1.06	0.35	0.00	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	10.66	2.67	1.33	1.33	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.00	6.62	1.53	0.00	0.00	0.00	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	30.15	7.74	1.87	0.27	0.53	0.80	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.18	8.88	1.51	1.13	0.19	0.94	0.38	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.61	6.14	0.61	0.61	0.00	0.00	1.23	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	9.79	4.08	1.63	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	27.90	7.08	1.04	1.87	0.62	1.25	0.62	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	25.50	9.53	1.68	1.68	0.28	0.28	1.40	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	28.85	9.27	1.03	1.03	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.93	8.13	2.32	0.58	0.87	0.00	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.13	6.58	1.49	0.30	0.60	1.49	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.56	8.85	1.66	0.00	1.11	0.00	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	25.80	10.25	2.12	0.71	0.71	0.00	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	21.39	9.96	1.48	1.48	0.00	1.11	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	10.36	1.15	2.30	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	30.32	8.06	1.92	0.77	0.38	1.15	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	25.48	3.96	0.57	1.70	0.00	1.13	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	35.28	7.38	1.64	0.00	0.00	2.46	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.18	6.78	3.16	1.81	0.45	1.36	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	18.67	10.77	2.15	0.72	0.00	0.00	0.72	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.17	9.71	0.00	1.49	0.75	0.00	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.53	5.57	1.86	1.49	0.00	0.37	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	31.44	9.91	1.72	0.86	0.43	0.43	1.29	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	14.56	8.56	0.86	0.00	1.71	0.00	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	32.65	7.66	1.67	1.00	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.32	9.65	2.41	0.60	0.60	1.21	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	39.82	10.66	2.84	1.42	0.00	0.71	0.00	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.53	8.25	1.03	1.03	0.00	0.00	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	28.98	5.90	2.68	0.00	0.00	0.54	0.54	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.93	6.73	0.00	1.35	0.67	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.19	6.30	0.74	1.48	1.48	0.37	0.00	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	38.38	6.98	0.00	2.33	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	12.69	2.12	2.12	0.00	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.41	9.60	1.60	0.80	0.80	1.20	1.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	24.71	8.00	0.00	0.73	1.45	0.00	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	38.33	8.43	3.83	3.83	0.00	1.53	0.77	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.68	6.91	3.95	0.99	0.49	0.00	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	6.59	0.00	0.94	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.20	7.54	0.50	0.50	0.00	0.50	0.50	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.49	7.66	2.25	0.45	0.00	1.35	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	1.72	0.00	3.44	0.00	0.00	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	9.35	2.23	1.78	1.34	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	22.68	6.65	0.39	0.39	0.00	0.39	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.09	7.26	0.00	1.32	0.00	0.00	0.66	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	31.14	7.26	2.08	1.04	0.52	1.04	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	26.25	4.38	0.88	2.19	0.88	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.16	10.62	0.56	0.00	0.00	0.56	0.00	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.29	7.07	4.42	0.44	0.44	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	31.24	8.49	2.70	0.77	0.77	0.77	1.16	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	21.27	6.58	0.51	1.01	0.00	0.00	1.01	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.59	5.77	0.96	0.96	1.92	0.48	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	28.23	9.54	1.59	0.40	1.59	0.80	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	5.47	0.61	1.22	0.61	0.61	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	8.99	0.00	0.69	0.69	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.12	6.08	3.04	0.38	0.38	0.76	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	12.39	0.52	1.03	1.03	1.55	1.55	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	7.86	0.60	1.21	1.21	0.60	0.00	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.52	6.97	3.17	0.95	0.00	0.32	0.95	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	24.52	7.46	1.07	1.60	1.60	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	9.19	1.72	1.72	0.00	0.57	2.30	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.65	6.17	1.54	0.51	2.57	1.03	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	30.42	10.61	1.41	2.12	2.12	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.73	10.21	0.00	1.13	0.57	1.70	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	26.63	7.49	0.83	1.25	0.83	0.42	0.00	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	7.05	0.00	0.00	0.00	0.00	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	10.86	2.51	1.25	0.84	0.42	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.02	10.22	0.46	1.39	0.93	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.10	7.36	1.34	0.67	0.67	0.67	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.78	12.30	0.53	1.07	1.07	0.53	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	31.12	8.49	1.62	0.81	0.40	0.40	0.00	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	26.62	9.18	0.00	1.84	0.00	0.00	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	5.33	0.00	0.89	0.89	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	7.41	0.57	1.71	0.57	0.57	0.57	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	37.58	9.97	0.77	1.53	0.00	1.53	3.07	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.87	16.42	0.55	1.09	0.00	0.55	1.64	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	26.28	4.90	2.23	0.45	0.45	0.45	0.89	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	38.73	8.32	2.34	1.56	1.04	0.26	0.52	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.20	10.61	1.99	0.00	0.00	0.00	0.66	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	6.24	2.08	2.08	0.00	4.16	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	13.90	3.42	0.91	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	21.47	11.38	1.28	0.00	0.73	0.18	0.18	1.65
Macrophage - monocyte derived, donor3	11389-118C3	24.25	5.51	1.31	0.13	0.52	0.00	0.00	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	49.38	21.24	1.06	1.59	1.06	2.66	2.66	0.53
Mallassez-derived cells, donor2	11929-125I3	28.52	4.60	1.43	1.27	1.43	0.95	0.95	0.32
Mallassez-derived cells, donor3	11930-125I4	30.44	6.25	1.67	0.83	1.25	0.42	0.56	0.14
Mammary Epithelial Cell, donor1	11273-116H4	39.36	12.95	2.49	3.59	3.59	2.69	2.99	0.40
Mammary Epithelial Cell, donor2	11350-117G9	33.01	11.00	3.19	4.34	2.90	3.19	2.61	0.29
Mammary Epithelial Cell, donor3	11422-118F9	59.36	15.22	3.49	3.74	0.75	2.74	3.24	0.50
Mast cell - stimulated, donor1	11487-119E2	2.03	3.39	0.00	0.68	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	20.11	3.03	0.76	1.08	0.22	0.00	0.00	0.65
Mast cell, donor2	11565-120D8	24.37	0.00	1.49	2.08	0.89	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	20.49	1.80	0.90	3.15	0.45	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	24.82	2.66	1.24	1.95	0.00	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	13.64	4.88	0.33	0.33	0.33	0.00	0.00	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	10.51	0.00	2.92	2.92	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	25.81	4.70	1.26	1.15	0.11	0.00	0.00	0.46
Mast cell, expanded, donor8	11941-126A6	15.90	3.18	1.00	10.38	2.34	0.00	0.00	1.17
Melanocyte - dark, donor1	11502-119F8	33.53	2.69	2.39	0.40	0.00	0.10	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	23.53	4.85	1.04	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	29.70	5.43	2.39	0.80	0.51	0.14	0.14	0.29
Melanocyte - light, donor1	11274-116H5	22.33	4.94	1.65	0.94	0.24	0.00	0.24	0.24
Melanocyte - light, donor2	11351-117H1	21.84	4.09	1.36	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	28.62	2.60	3.47	0.00	0.00	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	37.69	4.58	2.92	0.73	0.10	0.10	0.62	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	20.71	2.69	0.81	0.27	0.00	0.00	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	16.34	2.14	0.54	0.00	0.00	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	20.22	3.85	0.99	0.00	0.00	0.12	0.00	0.25
Meningeal Cells, donor2	11573-120E7	18.49	3.08	1.76	0.00	0.00	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	35.62	2.45	1.96	0.00	0.16	0.16	0.00	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	49.33	4.28	3.71	2.57	0.00	0.00	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.69	3.02	1.11	0.40	1.01	0.50	0.10	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	51.25	13.14	3.94	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	75.87	11.77	1.31	2.62	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	67.45	10.76	7.18	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.81	4.66	1.91	1.06	0.21	0.85	0.21	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.13	1.51	2.01	1.01	0.50	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	47.25	7.69	3.52	0.44	0.22	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	51.87	9.50	5.84	1.46	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	50.33	8.18	2.25	0.82	0.20	0.41	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.31	4.85	0.42	0.00	0.55	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.76	3.35	0.74	0.37	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.82	2.11	0.39	0.00	0.00	0.26	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.09	2.08	0.59	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	9.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	37.78	6.40	4.48	0.00	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	69.83	7.80	3.54	0.00	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	13.13	2.50	0.94	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	55.88	7.26	4.35	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	30.76	3.98	1.86	0.80	0.80	0.27	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	37.53	4.50	2.50	0.50	2.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	27.97	3.61	1.88	0.58	1.45	0.43	0.22	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	5.40	0.00	0.00	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	21.67	5.66	1.23	0.25	0.74	0.25	0.25	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.79	7.36	1.47	0.59	1.18	0.00	0.00	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	10.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.12	4.34	0.31	0.00	0.00	0.00	0.62	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	19.71	7.68	1.04	0.00	0.41	0.00	0.21	2.70
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.02	5.51	0.75	0.25	0.50	0.25	0.00	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	5.59	0.47	0.00	0.00	0.00	0.00	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.83	5.89	1.22	0.81	0.20	0.20	0.00	2.44
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.59	4.75	1.19	0.79	0.00	0.00	0.00	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	8.85	2.65	0.88	0.00	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.14	6.84	0.00	0.38	0.38	0.00	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	9.21	0.00	0.00	0.00	0.00	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.43	4.03	0.42	0.21	0.21	0.00	0.21	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	7.37	0.00	0.00	0.00	0.92	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.94	3.58	0.60	0.30	0.30	0.00	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.30	4.77	0.50	0.25	0.50	0.00	0.25	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.31	2.38	0.71	0.24	0.71	0.00	0.24	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	4.98	1.11	0.55	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.59	4.60	0.69	0.00	0.46	0.23	0.00	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	14.09	5.68	0.21	0.21	0.21	0.00	0.00	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.01	2.24	0.41	0.20	0.41	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.30	5.36	0.21	0.00	0.21	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.23	4.00	0.67	0.22	0.44	0.22	0.22	2.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.95	5.48	0.00	0.00	0.22	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	7.60	0.00	0.00	0.51	0.00	0.00	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	4.97	0.00	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.60	2.72	0.27	0.00	0.82	0.00	0.27	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	5.00	1.47	0.29	0.00	0.00	0.00	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	1.92	0.96	0.48	0.00	0.00	0.00	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.01	5.20	1.20	0.00	0.00	0.00	0.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	6.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.01	2.50	0.00	0.00	0.50	0.00	0.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	2.63	0.00	0.00	0.00	0.00	0.88	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	8.83	0.00	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	2.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.93	1.98	0.25	0.00	0.00	0.00	0.00	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	5.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	4.42	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.55	2.39	1.03	0.00	0.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.13	3.50	0.44	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	3.20	0.00	0.36	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.38	4.21	0.00	0.00	0.56	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	1.25	0.42	0.00	0.00	0.00	0.00	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	10.49	2.33	0.00	0.00	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.56	4.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.69	6.26	0.42	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	4.62	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.95	3.41	0.00	0.00	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.15	3.45	0.55	0.00	0.00	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.07	3.11	0.00	0.00	0.52	0.00	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.29	3.43	0.43	0.00	0.00	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	2.54	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.94	2.40	0.27	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.57	2.39	0.60	0.00	0.30	0.30	0.30	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.92	2.26	0.28	0.00	0.14	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.01	3.19	0.00	0.32	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.29	4.20	0.66	0.22	0.00	0.00	0.44	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	2.65	0.38	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.53	2.27	0.28	0.00	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	2.46	0.49	0.00	0.00	0.25	0.49	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	1.96	0.00	0.00	0.00	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.59	1.47	0.00	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.21	3.17	0.58	0.29	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	0.82	0.00	0.00	2.06	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.25	0.89	0.00	0.00	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	5.35	5.35	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.44	2.30	1.31	0.00	0.33	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	5.26	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.62	3.16	0.40	0.40	0.20	0.00	0.00	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	3.73	1.86	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.02	3.00	0.00	0.00	0.00	0.00	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.97	8.79	0.53	0.53	0.80	0.00	0.00	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.97	2.94	0.68	0.11	0.00	0.00	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	12.52	5.16	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.19	1.47	0.37	0.00	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	4.67	0.00	0.00	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	22.98	3.21	0.00	0.00	0.00	0.00	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	1.01	2.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	5.48	1.26	1.69	0.42	0.00	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	6.81	1.36	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.08	3.18	1.27	0.00	0.64	0.00	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	9.72	2.43	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	7.55	1.51	1.51	1.51	0.00	0.00	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	13.05	0.00	3.26	9.79	0.00	0.00	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	4.75	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	34.69	5.82	2.37	4.09	0.86	1.51	0.65	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.86	3.66	0.00	2.09	2.09	1.05	2.61	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	25.36	6.01	2.00	9.34	2.00	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	39.23	4.59	6.68	12.94	1.67	2.92	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	54.95	7.04	3.23	28.52	3.04	3.04	2.28	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	60.64	9.58	4.79	22.34	1.60	6.38	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.00	6.12	0.68	2.72	3.40	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	7.35	0.00	20.21	3.68	0.00	5.51	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.35	5.02	2.09	8.79	3.35	0.42	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	31.15	3.95	3.25	12.78	1.16	3.25	1.39	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.29	5.40	4.59	14.05	0.81	4.32	2.43	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.69	5.68	1.26	11.56	1.26	2.10	1.47	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.89	4.47	0.99	5.96	6.45	1.99	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.41	2.98	1.08	12.45	2.44	0.54	1.62	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	4.53	2.27	14.96	1.81	2.95	1.36	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.35	4.74	1.96	15.84	1.31	3.76	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.78	4.37	1.64	16.22	2.19	1.46	1.28	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	2.65	1.59	12.73	3.18	1.06	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	4.20	3.00	6.00	4.20	1.80	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	1.31	0.98	24.94	3.28	3.94	2.30	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.55	3.74	1.46	8.46	1.63	3.42	0.98	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.34	5.12	1.41	16.76	0.71	0.71	1.76	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	4.22	1.41	11.95	2.81	2.11	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.95	3.22	2.30	8.27	1.84	2.76	1.38	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.89	8.03	4.82	9.32	1.93	2.25	0.64	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	2.41	0.34	23.11	2.07	3.79	3.10	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	2.53	0.00	25.28	7.59	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.05	3.34	1.34	16.93	0.89	1.56	1.34	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.94	5.93	0.42	16.94	1.27	0.85	1.69	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.80	3.56	0.71	8.54	1.66	2.14	2.37	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	9.44	2.58	8.58	2.58	3.86	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.99	4.33	1.00	10.33	1.00	1.00	1.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	3.16	1.35	14.88	0.90	4.96	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.24	5.56	0.79	15.87	2.38	1.98	2.38	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	0.93	0.93	14.86	0.93	4.64	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	4.54	2.27	7.19	0.76	1.51	1.14	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.34	2.93	1.30	8.47	0.98	3.91	0.65	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	4.79	1.74	3.49	0.44	1.74	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.33	4.98	0.45	18.09	0.90	3.62	1.81	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	6.17	1.76	13.23	0.88	2.65	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	2.66	0.66	7.31	1.33	0.66	1.33	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	3.47	4.46	5.95	0.50	2.98	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	3.06	1.91	3.83	1.15	4.21	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.94	2.12	0.60	3.02	1.81	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.78	3.54	1.33	15.91	0.88	2.21	0.88	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	6.10	2.71	12.20	0.68	2.03	1.36	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	5.11	15.33	5.11	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	13.41	6.10	0.61	4.27	1.22	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.68	2.83	1.57	2.52	0.63	1.57	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.78	2.42	1.51	4.84	0.61	1.21	0.00	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.08	2.37	0.79	8.70	0.79	3.16	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	1.13	0.00	14.74	3.40	5.67	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	15.17	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	38.26	5.09	3.48	16.65	2.24	0.99	1.24	0.25
Myoblast, donor2	11322-117D8	35.48	7.48	1.53	20.71	2.30	1.53	1.53	0.77
Myoblast, donor3	11398-118D3	50.11	8.07	4.37	37.50	1.68	0.50	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.87	3.65	1.46	0.00	0.44	0.00	0.00	0.58
Natural Killer Cells, donor1	11230-116C6	9.84	0.00	0.62	11.69	0.00	0.00	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	10.86	1.21	0.00	9.35	0.30	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	8.47	0.18	0.55	7.36	0.00	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	40.29	7.98	3.63	0.00	0.00	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	46.22	3.85	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	103.55	6.83	6.83	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	129.90	6.83	4.62	0.44	0.44	0.44	0.44	0.22
Neurons, donor3	11655-122E8	81.39	4.93	1.64	0.00	2.47	0.82	1.64	0.82
Neutrophils, donor1	11233-116C9	1.86	0.00	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	0.00	0.00	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	10.33	2.02	0.59	0.12	0.12	0.36	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	13.68	1.95	0.98	0.98	0.33	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.84	5.62	1.20	1.00	0.80	0.40	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	13.49	3.72	1.65	3.85	2.06	0.83	0.69	0.28
Olfactory epithelial cells, donor2	11934-125I8	17.51	6.08	2.17	5.36	2.46	4.34	1.30	0.00
Olfactory epithelial cells, donor3	11935-125I9	15.78	4.65	1.48	3.75	3.18	3.52	0.79	0.11
Olfactory epithelial cells, donor4	11936-126A1	24.64	4.48	1.56	6.14	1.75	1.56	0.68	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	39.12	1.20	2.41	0.60	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	25.31	6.59	1.91	1.91	1.70	0.21	0.00	0.85
Osteoblast - differentiated, donor2	11353-117H3	36.58	8.00	4.57	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	24.21	16.14	3.72	3.72	1.24	3.10	1.86	0.00
Osteoblast, donor1	11277-116H8	108.86	15.24	8.01	3.13	0.39	1.17	0.59	0.59
Osteoblast, donor2	11354-117H4	42.14	4.92	6.32	0.70	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	85.84	12.62	7.29	3.02	1.24	1.42	0.89	0.00
Pancreatic stromal cells, donor1	11249-116E7	22.58	4.80	2.27	1.85	1.60	0.34	0.34	0.34
Pericytes, donor1	11491-119E6	18.92	4.45	1.11	0.22	0.33	0.22	0.11	0.11
Pericytes, donor2	11571-120E5	24.67	9.73	1.36	6.56	0.23	0.68	0.68	0.00
Pericytes, donor3	11652-122E5	38.45	8.14	1.83	0.41	0.81	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	29.72	1.58	2.03	0.57	0.23	0.11	0.23	0.00
Perineurial Cells, donor2	11579-120F4	21.99	2.58	2.39	0.09	0.00	0.00	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6.37	0.64	0.32	4.14	0.00	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.33	0.98	0.00	0.49	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	6.73	0.52	0.78	3.88	0.26	0.00	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	109.54	27.03	8.13	0.24	0.48	5.02	8.61	1.43
Placental Epithelial Cells, donor2	11355-117H5	62.10	17.74	5.54	0.00	1.11	2.22	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	71.66	14.14	3.73	0.39	0.00	5.30	2.75	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	31.65	11.71	2.85	2.85	1.58	0.95	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	16.51	5.44	0.56	1.88	1.50	0.00	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.01	1.44	1.04	0.26	1.17	0.13	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	36.02	7.43	4.05	0.23	0.68	0.45	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	21.21	4.26	0.96	1.49	0.85	0.53	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	22.70	4.36	1.75	1.31	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	41.97	6.88	2.72	1.58	0.72	0.14	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	21.65	8.86	0.00	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	82.92	16.58	4.61	1.84	1.54	0.00	0.61	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	58.08	9.39	6.02	0.71	0.89	1.06	0.18	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	55.34	12.26	5.11	1.36	1.02	0.51	0.17	0.51
Preadipocyte - visceral, donor1	11280-116I2	49.09	6.43	3.26	2.14	1.68	0.65	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	43.26	2.76	1.84	0.00	2.30	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	37.51	7.73	3.34	1.57	1.57	1.67	0.52	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	19.01	2.87	1.66	0.00	0.00	0.30	0.15	1.21
Prostate Epithelial Cells, donor2	11331-117E8	26.27	7.04	0.54	1.49	2.03	0.54	0.41	0.54
Prostate Epithelial Cells, donor3	11404-118D9	38.15	8.57	2.88	4.41	2.33	2.08	2.88	0.24
Prostate Stromal Cells, donor1	11254-116F3	37.93	4.90	1.59	0.80	0.91	0.68	0.46	0.23
Prostate Stromal Cells, donor2	11332-117E9	44.65	9.14	2.69	1.26	0.54	0.72	0.54	1.08
Prostate Stromal Cells, donor3	11405-118E1	17.41	4.59	1.46	0.42	0.31	0.31	0.00	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	57.67	8.76	3.65	0.73	0.73	1.82	1.82	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	44.71	1.94	1.32	1.04	1.39	1.11	1.59	0.07
Renal Epithelial Cells, donor1	11517-119H5	116.66	14.20	9.13	1.01	1.01	2.03	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	62.60	13.52	3.56	2.85	0.00	2.85	3.56	0.71
Renal Epithelial Cells, donor3	11678-122H4	49.02	1.69	1.59	1.59	2.01	0.95	1.48	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.70	6.81	2.04	0.00	0.00	0.68	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.72	6.06	2.29	2.02	0.67	0.54	0.40	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.06	4.88	3.77	1.33	0.00	0.22	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	56.56	13.97	3.33	1.33	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	64.71	5.72	4.40	1.54	0.66	0.88	1.32	0.22
Renal Mesangial Cells, donor2	11598-120H5	50.79	10.66	4.39	0.63	0.63	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	61.03	4.99	3.61	1.39	0.55	1.94	0.83	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	53.95	6.17	3.49	0.81	0.54	0.27	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.05	5.06	2.11	0.42	1.27	2.11	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	68.85	8.87	5.98	1.16	1.16	1.74	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	50.04	6.74	4.15	0.00	0.52	0.78	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	32.69	3.41	1.14	0.00	0.57	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	46.31	8.23	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.07	1.51	1.00	0.00	0.25	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	10.69	2.14	0.53	0.13	0.67	2.54	0.94	3.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	6.25	9.83	0.89	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.60	1.10	0.55	0.00	0.00	0.00	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.92	3.48	0.58	0.58	0.58	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.12	4.55	1.30	0.00	0.13	0.00	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.69	6.95	1.89	0.10	0.30	0.10	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	42.83	7.03	2.68	0.45	0.11	0.11	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	34.98	4.84	1.49	0.25	0.00	0.25	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	35.90	7.58	2.80	0.93	0.23	0.12	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	36.75	8.09	4.16	0.00	0.23	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.42	4.24	1.23	0.55	0.00	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	30.56	6.66	2.72	0.15	0.45	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.66	8.24	3.05	0.00	0.18	0.18	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	20.37	7.60	0.57	0.14	0.00	0.00	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	31.87	6.33	3.00	0.43	0.11	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	39.39	7.30	4.43	0.89	0.00	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.57	5.74	0.96	0.57	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	30.00	5.87	3.17	0.19	0.00	0.00	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	29.88	6.01	2.82	0.19	0.38	0.00	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.12	5.97	1.33	0.13	0.00	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	36.02	5.74	2.92	0.19	0.10	0.00	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	39.53	3.82	3.25	0.00	0.00	0.00	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.48	4.16	1.92	0.21	0.11	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	33.08	1.68	4.20	0.56	0.56	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	41.02	7.35	2.05	0.17	0.34	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.77	5.29	2.01	0.18	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	29.92	5.89	2.45	0.12	0.37	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.31	7.39	3.90	0.13	0.27	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.91	7.08	0.24	0.24	0.00	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	32.54	7.34	2.98	0.20	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	41.86	8.42	3.74	0.23	0.00	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.38	8.09	0.83	0.21	0.21	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	34.29	7.96	2.88	0.66	0.66	0.00	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	37.39	7.73	5.43	0.42	0.21	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	18.03	6.06	1.62	0.40	0.13	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.70	5.79	2.72	0.00	0.00	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	36.05	8.29	3.86	0.00	0.19	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.96	5.85	1.20	0.52	0.17	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.49	8.37	2.47	0.27	0.27	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	40.22	7.06	3.61	0.82	0.33	0.33	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.80	6.14	1.19	0.34	0.00	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	37.73	6.21	3.70	0.15	0.15	0.15	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.58	6.13	3.73	0.80	0.00	0.00	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	11.75	5.25	1.38	0.14	0.00	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.24	7.86	2.62	0.00	0.00	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	26.20	4.84	2.02	0.20	0.00	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	13.56	3.86	1.04	0.00	0.19	0.09	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	17.12	3.14	3.49	0.35	0.35	0.00	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	30.22	8.16	0.91	0.60	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.16	5.39	1.47	0.00	0.00	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	20.23	5.39	1.02	0.15	1.16	0.15	0.15	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	32.86	4.26	3.65	1.83	0.00	0.00	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.07	6.33	1.51	0.00	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.90	5.88	1.81	1.58	0.23	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.35	5.99	2.10	0.90	1.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	11.57	4.84	0.12	1.06	0.12	0.00	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.25	8.96	2.13	0.85	1.07	0.00	0.64	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.25	7.21	1.80	1.20	0.60	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	47.58	10.16	4.89	0.56	0.19	0.19	0.56	0.19
Schwann Cells, donor2	11578-120F3	57.84	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	52.14	5.48	2.85	0.44	0.22	1.53	0.22	0.22
Sebocyte, donor1	11220-116B5	22.46	7.67	3.83	1.64	2.19	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	27.11	8.27	0.46	3.22	0.46	2.30	1.38	0.00
Sebocyte, donor3	11378-118B1	32.57	7.63	2.47	1.65	0.21	0.62	0.82	0.62
Sertoli Cells, donor1	11255-116F4	33.13	11.60	3.31	3.31	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	33.89	14.12	0.00	8.47	11.30	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	52.08	13.37	3.87	18.83	0.79	1.94	2.20	0.44
Skeletal Muscle Cells, donor2	11358-117H8	60.00	18.07	2.17	10.84	0.00	6.51	2.89	0.00
Skeletal Muscle Cells, donor3	11430-118G8	132.09	24.25	10.03	14.21	1.67	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	44.30	7.85	3.61	2.20	0.16	0.16	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	39.09	8.62	3.27	4.01	0.30	0.15	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	54.48	8.62	3.69	5.69	0.46	0.46	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.97	3.91	1.64	0.38	0.13	0.25	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.39	6.28	2.28	1.43	0.57	0.29	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	71.93	9.42	4.66	5.65	0.20	0.40	0.30	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	49.12	10.11	3.54	14.32	0.42	2.78	2.61	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	120.14	20.99	7.96	24.61	0.72	0.72	2.17	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	52.29	21.33	3.30	11.83	1.10	2.34	2.20	0.83
Skin - palm, donor1	10286-104F7	16.12	29.55	5.37	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.61	8.79	1.73	2.59	0.86	1.30	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	3.27	0.00	1.64	11.45	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.03	14.67	1.82	1.69	1.43	0.52	0.65	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	35.17	9.59	1.81	4.17	2.22	2.36	1.39	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	32.07	9.85	1.41	4.22	1.83	2.11	1.69	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	11.42	2.96	1.48	0.42	9.73	0.21	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	39.12	12.74	2.70	2.70	1.50	1.35	1.57	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.21	4.94	0.62	5.86	3.70	0.31	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.34	1.33	0.44	1.11	6.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	78.18	5.29	5.29	5.29	1.18	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.71	3.98	2.21	1.10	0.44	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	81.12	8.66	2.76	9.06	1.18	0.39	0.79	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	63.35	9.27	4.64	1.55	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	55.89	6.25	2.66	4.13	1.60	0.93	0.27	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	39.68	6.21	4.43	4.21	1.77	0.66	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.43	11.65	3.20	7.30	1.79	1.79	1.15	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.40	2.60	2.28	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	41.64	3.25	2.95	0.30	0.89	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.63	1.57	2.42	0.14	0.00	0.14	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	44.74	8.13	1.79	0.49	0.16	0.16	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.79	2.44	0.30	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	51.02	10.61	4.04	1.52	1.26	0.25	0.76	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	6.12	30.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	46.73	8.11	3.81	5.25	0.95	0.95	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.92	3.83	1.18	0.00	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.38	4.95	1.51	0.00	0.00	0.00	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.27	5.14	2.10	0.10	0.10	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	71.46	12.84	5.41	4.80	2.17	1.24	1.08	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	73.30	10.78	3.23	17.25	1.08	2.16	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	58.87	10.76	2.99	5.98	2.69	1.20	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	50.87	8.53	2.73	0.34	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.89	1.73	1.10	0.16	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.91	6.14	1.61	12.68	5.13	1.21	1.81	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.86	5.46	2.50	1.82	1.82	0.00	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.78	10.87	1.81	1.81	4.23	2.42	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.16	7.68	4.24	0.53	0.26	0.00	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.25	5.73	1.73	0.67	0.40	0.40	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.66	5.51	1.00	0.63	0.13	0.38	0.00	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.68	4.06	1.01	0.51	0.76	0.76	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	64.68	9.35	4.37	3.02	1.21	0.45	0.75	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	79.52	12.75	5.25	0.75	1.50	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	34.89	3.88	0.00	1.29	0.00	0.00	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	74.41	7.91	3.26	3.26	2.33	0.00	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.41	10.10	2.52	5.55	3.53	1.01	2.52	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.94	7.83	0.94	6.89	2.19	0.31	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.96	5.01	0.88	0.88	0.00	0.29	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.07	6.75	4.17	0.50	0.25	0.00	0.33	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.28	4.20	1.87	0.93	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	52.39	6.76	3.02	4.32	1.01	0.43	0.14	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	84.14	7.90	7.39	5.10	1.53	0.76	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	55.28	11.47	3.76	2.26	2.26	1.32	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	36.33	3.21	2.24	0.14	0.14	0.00	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.32	3.60	2.01	0.08	0.08	0.17	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	40.95	5.24	1.43	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	56.76	8.81	3.91	4.40	0.98	0.98	0.24	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.92	7.07	1.33	0.44	1.10	0.22	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	44.76	7.31	4.39	0.29	2.05	0.88	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.66	1.94	0.78	0.19	0.58	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.54	7.40	0.53	1.85	1.32	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	0.74	0.37	2.23	1.86	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	9.34	3.23	0.00	1.08	0.36	0.00	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	19.59	4.54	0.28	2.84	3.12	0.57	0.00	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.48	4.33	3.15	0.00	0.39	0.79	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	9.40	3.05	0.00	1.27	2.03	0.25	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	11.58	1.60	0.40	0.80	1.60	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	13.38	2.93	1.25	0.00	1.25	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.83	3.21	0.92	0.92	1.83	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	21.55	4.04	1.68	7.41	2.36	1.35	1.01	0.34
Synoviocyte, donor2	11368-117I9	20.28	6.37	2.01	4.02	3.35	3.52	2.18	0.50
Synoviocyte, donor3	11440-118H9	12.29	7.37	0.89	4.92	1.34	4.69	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	40.02	12.15	4.29	0.36	0.00	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	36.82	5.79	2.78	0.00	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	61.36	12.69	3.37	1.86	0.79	1.08	0.86	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	63.40	14.69	4.64	3.87	0.00	1.93	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	43.52	18.33	2.29	1.15	0.57	0.00	2.86	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.43	2.46	1.11	0.00	0.37	1.97	0.98	2.09
Urethra, donor2	10319-105A4	5.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	36.13	9.83	1.86	2.66	0.53	0.27	1.06	0.00
Urothelial Cells, donor2	11600-120H7	39.26	10.41	1.20	1.60	0.80	0.80	0.40	0.40
Urothelial Cells, donor3	11681-122H7	41.49	7.33	3.44	2.52	1.15	0.92	0.92	0.00
Urothelial cells, donor0	11216-116B1	27.64	5.80	2.45	0.89	0.67	0.45	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	1.78	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.85	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.89	0.00	0.34	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	7.55	1.16	1.16	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	3.12	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	0.91	2.74	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	23.44	8.39	1.85	0.00	0.12	0.12	0.00	0.49
Wilms' tumor cell line:HFWT	10597-108E3	37.84	16.72	1.76	0.88	0.00	0.88	5.28	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	32.68	14.80	3.63	0.28	0.28	0.00	1.40	0.28
achilles tendon, donor2	10292-104G4	10.33	4.13	0.00	0.00	4.13	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	52.27	7.14	3.57	0.00	0.00	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	36.68	8.13	3.02	0.46	0.00	0.00	0.00	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.32	3.92	2.02	0.00	0.00	0.00	0.00	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	56.06	4.90	4.63	0.00	0.00	0.00	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	59.31	9.56	3.94	0.00	0.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	38.70	9.73	3.81	0.00	0.00	0.00	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.68	10.34	1.36	2.72	1.36	0.27	0.54	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	52.88	10.13	2.20	0.88	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	31.04	10.62	1.23	0.41	0.00	0.41	0.00	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.87	10.10	4.27	0.39	0.00	0.00	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	71.21	12.14	2.02	0.00	0.00	0.00	0.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	3.90	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.81	11.15	2.32	0.46	0.00	0.00	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	32.88	3.88	1.55	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	42.38	3.80	5.55	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.06	6.97	0.00	0.00	0.00	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	19.74	10.69	0.82	0.00	0.82	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	31.62	6.45	2.76	0.31	0.00	0.00	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	38.40	2.99	3.41	0.85	0.00	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	28.21	4.85	2.73	0.00	0.00	0.00	0.00	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	41.40	3.13	2.65	0.00	0.00	0.00	0.00	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	56.35	3.34	2.23	0.00	0.00	0.00	0.00	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.70	4.34	2.67	0.00	0.00	0.00	0.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	18.58	5.57	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	59.89	7.91	1.51	0.38	0.00	0.00	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.87	6.54	2.18	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	16.87	0.00	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.84	8.48	3.53	0.00	0.00	0.00	0.00	1.41
adipose tissue, adult, pool1	10010-101C1	11.32	2.79	0.78	0.47	0.16	0.00	0.00	0.00
adipose, donor1	10184-103D4	45.74	1.76	1.76	0.00	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	13.79	0.41	0.41	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	27.23	3.00	1.91	0.00	0.00	0.00	0.27	0.54
adipose, donor4	10187-103D7	85.81	0.87	3.47	0.87	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	73.07	11.68	4.42	0.32	0.00	0.16	0.32	2.05
adrenal gland, adult, pool1	10081-102A9	10.91	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.61	2.53	0.53	0.00	0.00	0.00	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	28.23	6.07	3.22	0.00	0.71	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	63.76	19.94	6.03	0.00	2.55	6.49	2.09	0.00
amniotic membrane cells, donor2	12236-129G4	36.52	5.75	3.72	0.34	0.00	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	53.03	11.49	1.47	0.00	4.12	3.54	1.18	0.00
amygdala - adult, donor10196	10167-103B5	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	9.53	1.01	0.81	0.20	0.20	0.00	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	5.49	1.94	0.00	0.00	0.32	0.00	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	20.75	2.67	1.27	1.91	0.89	0.13	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	58.47	7.50	5.07	0.22	0.44	0.44	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.08	12.36	2.34	0.00	0.00	0.00	0.00	0.33
aorta, adult, pool1	10052-101G7	15.89	2.35	2.55	1.57	0.20	0.20	0.00	0.20
appendix, adult	10189-103D9	12.42	1.55	0.78	3.88	0.00	0.00	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	20.98	3.10	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	9.51	2.72	0.00	2.72	0.00	0.00	0.00	4.08
astrocytoma cell line:TM-31	10425-106D2	24.92	15.94	2.90	1.30	1.45	0.00	0.58	0.00
b cell line:RPMI1788	10427-106D4	24.68	1.78	0.89	0.15	0.30	0.00	0.00	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.96	4.99	3.05	6.10	3.88	1.11	1.11	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	47.53	7.74	3.77	1.98	0.79	0.79	0.69	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	21.26	2.34	3.35	0.33	0.50	0.33	0.67	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	5.59	0.00	0.00	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	10.97	1.96	0.43	0.43	0.11	0.00	0.00	0.11
blood, adult, pool1	10053-101G8	6.64	0.00	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	12.85	3.43	11.99	1.71	1.71	0.00	0.00
bone marrow, adult	10192-103E3	11.47	0.67	0.67	0.67	0.00	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	7.18	1.03	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	3.45	1.00	0.67	0.11	0.00	0.00	0.00	0.00
brain, fetal, pool1	10085-102B4	50.76	5.34	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	46.25	5.95	0.99	0.66	0.33	0.66	0.33	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.20	8.49	1.00	4.12	1.37	0.37	0.50	2.87
breast, adult, donor1	10080-102A8	21.47	0.63	1.89	0.63	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	25.66	40.27	4.95	0.76	0.00	0.25	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	49.17	41.13	6.18	2.78	1.55	0.93	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	66.76	5.76	1.38	0.00	1.84	0.69	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	24.93	11.62	0.97	0.24	0.97	0.73	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	52.66	5.17	1.88	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.16	24.06	3.39	0.33	1.20	0.44	1.20	3.94
carcinoid cell line:SK-PN-DW	10719-109I8	27.57	1.58	0.00	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	28.48	2.93	0.80	0.00	0.00	0.00	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	2.30	1.15	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	7.03	1.00	0.84	0.00	0.00	0.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	2.29	2.29	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	4.39	2.20	0.00	0.00	0.73	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	3.84	0.64	0.21	0.43	0.00	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	3.79	0.69	0.69	0.00	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	7.47	0.83	0.00	0.00	0.00	0.00	0.00	1.66
cerebral meninges, adult	10188-103D8	8.57	3.03	0.50	0.25	0.00	0.00	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	4.39	0.73	2.92	0.00	0.00	0.00	2.19
cervical cancer cell line:D98-AH2	10552-107I3	52.05	8.48	2.73	0.43	0.14	0.29	0.29	0.86
cervical cancer cell line:ME-180	10553-107I4	20.38	6.46	1.33	0.17	2.32	0.33	0.00	0.50
cervix, adult, pool1	10013-101C4	13.86	3.04	1.36	0.73	0.10	0.00	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.81	1.39	1.95	2.65	0.84	0.42	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	2.61	2.61	1.31	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	44.74	3.48	1.99	0.00	0.12	0.37	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	17.00	6.04	1.48	0.00	0.25	0.25	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	27.75	18.50	1.66	0.00	0.00	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	40.74	21.37	2.85	0.00	1.42	14.53	3.13	0.00
chorionic membrane cells, donor2	12239-129G7	42.76	6.46	3.18	1.39	0.80	4.08	2.59	0.50
chorionic membrane cells, donor3	12240-129G8	35.17	24.18	3.30	0.00	1.65	18.68	7.14	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	36.35	12.12	1.01	0.00	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	45.34	8.07	5.19	0.38	0.00	0.19	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	38.01	17.95	5.07	2.11	0.00	0.00	0.00	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	29.53	4.88	1.28	0.00	0.00	0.00	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.07	11.61	2.18	0.00	0.00	0.00	0.00	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	30.54	7.13	1.22	0.00	0.41	0.00	0.00	2.85
chronic myelogenous leukemia cell line:K562	10454-106G4	61.84	10.89	4.42	0.00	0.29	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	48.48	7.04	4.69	2.09	0.26	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	49.60	8.23	1.83	1.14	1.37	0.46	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	17.87	3.64	1.74	0.00	0.35	0.35	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	18.67	4.39	2.38	0.00	0.18	0.00	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	45.99	4.56	1.52	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	17.85	7.14	5.95	0.00	0.00	0.00	0.00	2.38
colon, adult, pool1	10014-101C5	12.69	3.17	1.41	0.24	0.24	0.00	0.00	3.76
colon, fetal, donor1	10070-101I7	5.56	0.62	1.24	0.62	0.00	0.00	0.00	4.33
common myeloid progenitor CMP, donor1	12130-128D6	77.92	13.75	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.20	8.07	1.27	0.00	0.42	2.12	2.97	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	24.45	12.68	2.11	0.30	0.45	0.60	1.81	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	21.29	10.72	2.54	0.42	0.14	0.99	1.55	2.68
corpus callosum, adult, pool1	10042-101F6	6.85	1.11	0.22	0.11	0.11	0.00	0.00	0.11
cruciate ligament, donor2	10295-104G7	8.92	1.62	0.00	0.00	0.81	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	12.84	12.84	2.41	1.61	0.00	0.00	0.00	2.41
diencephalon, adult	10193-103E4	6.00	2.16	0.24	0.00	0.24	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	40.18	3.44	2.53	0.00	0.00	0.00	0.00	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	50.26	17.44	1.28	0.26	3.33	2.31	1.03	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.78	1.44	2.17	0.96	0.24	0.96	1.44	0.00
ductus deferens, adult	10196-103E7	11.46	2.49	1.00	1.50	0.00	0.00	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	2.88	1.44	0.00	0.00	0.00	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	8.83	1.47	0.74	2.21	0.00	0.00	0.00	2.21
dura mater, adult, donor1	10041-101F5	10.57	2.97	1.07	0.25	0.17	0.08	0.00	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	52.85	10.22	1.11	0.22	0.00	0.00	0.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	56.46	4.87	2.44	0.14	0.14	0.00	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	22.20	1.85	0.00	6.78	2.47	3.08	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	21.49	5.15	3.03	3.63	2.12	1.21	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.76	4.01	2.78	4.63	0.93	3.09	1.85	0.00
embryonic pancreas cell line:2C6	10603-108E9	31.52	5.25	1.31	9.19	0.00	2.63	5.25	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	19.11	4.02	1.01	0.00	0.00	0.34	1.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	61.44	8.52	5.07	13.23	3.26	0.72	1.63	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.09	2.25	1.77	0.00	0.32	0.48	0.16	0.96
epidermoid carcinoma cell line:A431	10426-106D3	33.24	14.23	1.67	0.67	0.44	0.67	2.45	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	58.73	11.44	3.63	0.77	0.77	2.20	3.52	0.77
epididymis, adult	10197-103E8	11.72	2.30	1.26	1.05	0.00	0.00	0.00	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.97	6.39	4.08	2.66	4.79	1.60	1.06	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.58	6.69	0.79	0.79	0.39	0.39	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.82	8.39	2.49	0.13	1.05	0.13	0.13	2.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.62	7.18	1.48	0.20	0.69	0.30	0.00	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	45.71	8.51	3.92	0.34	0.56	0.11	0.45	1.01
esophagus, adult, pool1	10015-101C6	24.63	7.22	1.06	0.53	0.42	0.11	0.11	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	12.77	2.63	1.38	0.13	0.00	0.00	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	2.41	9.66	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	14.73	2.10	6.31	0.00	0.00	0.00	4.21
eye - muscle medial, donor2	10299-104H2	4.46	17.86	1.49	1.49	0.00	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	11.46	9.17	2.29	2.29	0.00	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	8.74	1.46	0.00	0.00	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	11.44	1.53	0.51	1.53	0.00	0.00	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	32.18	4.36	3.33	1.80	0.77	0.38	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	69.09	11.16	5.94	5.46	1.90	0.24	1.19	0.95
frontal lobe, adult, pool1	10040-101F4	3.75	1.31	0.09	0.09	0.00	0.00	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	32.73	4.50	2.40	0.00	0.30	0.90	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.01	5.67	2.83	0.27	0.18	0.37	0.18	0.18
gall bladder, adult	10198-103E9	9.90	2.17	0.48	0.48	0.48	0.00	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	11.27	3.76	2.68	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	6.72	0.37	1.12	0.75	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	41.19	8.03	2.53	1.06	1.48	2.53	2.32	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.86	9.28	3.29	0.19	0.00	0.19	0.19	0.58
gastric cancer cell line:AZ521	10549-107H9	41.15	4.10	0.82	0.33	0.00	0.16	0.33	0.49
gastric cancer cell line:GSS	10560-108A2	33.86	0.92	5.49	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	7.08	1.60	0.46	0.00	0.00	0.00	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	28.23	4.93	1.38	0.57	0.69	0.11	0.23	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	29.95	1.40	1.82	2.24	2.38	1.26	1.96	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.18	13.22	2.24	1.25	0.25	1.00	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.84	3.27	2.53	1.37	1.37	0.21	0.74	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.69	2.11	4.49	1.69	0.98	0.98	0.70	0.70
glioblastoma cell line:T98G	10485-107A8	19.32	7.28	3.97	0.55	0.22	0.22	0.11	0.22
glioma cell line:GI-1	10413-106B8	26.65	2.34	5.27	0.00	0.59	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	1.46	2.19	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	12.20	0.73	1.22	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	4.11	4.11	0.00	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	9.06	4.26	1.07	0.53	0.00	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	90.54	12.24	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	10.45	0.00	0.00	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	36.16	7.04	1.92	2.88	1.28	0.64	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	31.68	1.84	0.46	0.00	0.00	0.00	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	25.61	3.20	0.46	0.00	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	25.76	2.58	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	38.81	0.00	0.00	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	31.55	1.37	0.00	0.00	0.00	0.00	0.00	1.37
hIPS, biol_rep3	14382-156B8	7.72	1.10	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	29.02	5.17	1.72	1.44	0.00	0.00	0.29	0.86
heart - mitral valve, adult	10205-103F7	6.88	2.09	0.60	0.90	0.00	0.00	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	8.89	2.61	1.05	0.26	0.26	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	15.82	7.49	1.67	0.00	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	19.39	6.12	0.82	0.00	0.00	0.82	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	5.96	1.70	1.28	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	20.93	4.37	1.38	0.23	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	11.40	1.95	0.92	0.00	0.00	0.00	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.06	5.24	1.23	3.70	0.62	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	2.38	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	18.89	3.31	1.33	0.00	0.11	0.00	0.11	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.85	3.88	1.94	0.00	0.00	0.00	0.12	2.91
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.03	2.22	2.02	0.00	0.00	0.00	0.00	1.92
hepatoma cell line:Li-7	10484-107A7	11.23	3.78	2.00	0.00	0.11	0.00	0.00	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.38	4.22	2.71	0.00	0.00	0.00	0.00	0.30
hippocampus - adult, donor10196	10169-103B7	3.79	1.89	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	11.43	0.82	0.20	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	1.00	1.49	0.00	1.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	11.28	2.47	0.70	0.00	0.00	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	131.83	1.83	3.66	0.00	0.61	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	97.59	1.96	2.95	0.00	0.00	0.00	0.00	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	96.99	1.78	3.05	0.00	0.00	0.25	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.32	0.56	2.26	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	37.44	1.55	1.55	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	52.77	1.90	1.90	0.00	0.00	0.00	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	16.64	1.75	1.46	0.00	0.00	0.29	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.34	2.37	0.86	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.85	1.67	1.67	0.00	0.00	0.00	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.88	5.21	2.13	0.00	0.24	0.24	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	36.16	4.98	2.09	0.16	0.16	0.32	0.00	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	47.80	5.39	2.69	0.00	0.00	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.05	1.41	1.72	0.00	0.16	0.16	0.00	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	67.31	0.00	2.46	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	68.07	0.00	0.87	0.00	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.65	1.15	1.34	0.00	0.00	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.34	2.18	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	33.48	0.50	0.50	0.00	0.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.06	0.19	1.51	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.28	2.27	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.84	1.88	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.60	1.80	2.12	0.00	0.00	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.97	1.74	0.87	0.00	0.00	0.00	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.82	2.69	2.69	0.00	0.00	0.00	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	89.42	1.66	2.40	0.00	0.00	0.18	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	79.02	2.28	2.85	0.00	0.29	0.00	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	110.65	0.82	2.04	0.00	0.41	0.00	0.00	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	29.57	1.41	1.41	0.00	0.00	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.97	1.90	2.22	0.00	0.00	0.32	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	41.46	3.03	1.21	0.30	0.00	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	16.55	2.59	0.00	0.00	0.00	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.95	1.99	1.33	0.00	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	24.63	1.28	0.77	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.47	2.05	1.53	0.00	0.00	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	20.45	0.76	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.52	3.02	2.02	0.00	0.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	89.36	1.69	3.38	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	102.95	0.89	2.23	0.00	0.00	0.00	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	86.34	0.49	5.85	0.00	0.00	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.53	0.31	0.92	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.00	0.33	0.99	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.99	2.74	0.55	0.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.97	2.90	1.45	0.36	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.51	2.49	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	3.58	0.00	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	33.59	3.52	1.63	0.14	0.14	0.00	0.14	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.63	3.50	0.54	0.27	0.00	0.00	0.00	0.54
immature langerhans cells, donor1	11904-125F5	10.90	3.87	0.73	0.24	0.24	0.00	0.97	0.00
immature langerhans cells, donor2	11905-125F6	11.88	9.51	0.00	0.00	0.00	1.58	2.38	0.00
insula, adult, pool1	10039-101F3	5.87	1.42	0.19	0.00	0.00	0.00	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	13.01	9.75	2.28	0.00	0.98	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	15.42	2.00	1.10	0.40	0.00	0.00	0.00	2.20
kidney, fetal, pool1	10045-101F9	14.78	1.13	0.85	0.00	0.21	0.00	0.14	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	57.23	9.80	3.98	0.28	1.56	3.69	2.13	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.01	2.76	1.11	0.00	0.41	0.00	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.94	9.17	1.83	3.12	1.10	0.92	1.10	0.18
left atrium, adult, donor1	10079-102A7	10.90	2.18	1.09	0.00	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	8.09	3.03	2.53	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	30.10	18.61	3.56	0.55	0.27	0.27	0.00	1.64
leiomyoma cell line:10964C	10569-108B2	39.88	7.90	1.08	5.75	1.08	2.16	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	32.07	8.15	0.00	1.63	2.17	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	40.31	5.83	1.70	5.83	3.40	0.73	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	4.18	0.00	1.05	1.05	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	55.49	5.43	4.25	1.30	0.59	0.00	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	27.65	5.31	2.19	4.53	2.19	0.16	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	22.91	11.94	2.68	0.49	0.12	0.00	0.24	0.24
liver, adult, pool1	10018-101C9	10.21	1.46	1.30	0.16	0.16	0.00	0.16	2.27
liver, fetal, pool1	10086-102B5	12.23	0.00	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	4.37	1.31	0.15	0.29	0.00	0.00	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	9.04	1.48	0.18	0.37	0.18	0.00	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	3.67	1.97	0.28	0.00	0.28	0.00	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	7.57	0.42	0.84	0.42	0.42	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	18.27	1.25	1.11	0.28	0.42	0.14	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	29.64	10.34	2.76	0.00	2.07	1.38	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.51	17.93	5.27	1.32	1.45	0.79	0.79	0.26
lung, adult, pool1	10019-101D1	11.46	1.18	0.47	0.24	0.00	0.00	0.00	0.00
lung, fetal, donor1	10068-101I5	4.00	0.57	0.00	0.57	0.00	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	5.04	1.83	1.83	0.92	0.00	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	8.99	2.84	1.42	0.00	0.00	0.00	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	29.59	4.16	1.10	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.71	5.28	2.41	2.11	0.00	0.00	0.00	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	28.03	10.19	0.85	3.40	2.55	1.70	4.25	0.00
mature adipocyte, donor1	12231-129F8	14.21	4.00	0.89	0.44	0.44	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	12.66	2.49	1.45	0.21	0.62	0.21	0.21	0.62
mature adipocyte, donor3	12233-129G1	10.19	2.61	2.13	0.24	0.47	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	11.06	3.42	0.53	0.00	0.79	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	37.17	5.96	2.14	0.00	0.24	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	5.64	1.13	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	5.33	1.29	0.37	0.18	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	2.22	0.32	0.32	0.00	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	4.69	1.28	0.43	0.00	0.43	0.00	0.00	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	3.38	0.84	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	7.22	2.12	0.21	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.54	3.59	1.08	0.00	0.36	0.00	0.00	3.95
medulla oblongata - adult, donor10196	10174-103C3	5.19	1.30	0.00	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	11.46	1.24	0.46	0.31	0.46	0.00	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	6.45	1.47	0.57	0.24	0.00	0.00	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	9.37	2.78	0.35	1.39	0.35	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	24.36	3.32	0.44	0.00	0.22	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	40.47	12.35	5.01	1.22	0.24	0.12	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	17.11	2.59	1.01	0.00	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	16.83	6.52	1.36	0.00	0.00	0.00	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	22.79	7.24	1.63	0.54	1.81	0.18	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	38.77	11.46	3.52	0.88	0.00	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	54.96	18.40	3.11	0.00	0.26	0.26	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	54.93	8.29	3.84	1.38	1.69	0.92	0.46	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.72	4.36	2.00	0.36	0.91	0.18	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	5.80	4.14	0.41	2.07	1.66	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.02	3.93	1.69	2.25	1.12	0.28	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	27.54	5.58	0.39	1.93	1.35	0.19	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.74	4.86	0.00	4.86	2.78	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.86	4.12	0.69	1.03	2.06	0.86	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.60	6.21	0.92	0.92	1.38	0.69	0.35	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	47.48	5.44	2.92	0.66	0.93	0.27	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	40.92	4.86	2.16	2.57	2.03	0.81	0.27	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	45.10	2.42	1.14	0.85	0.71	0.14	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.83	2.31	1.65	0.33	0.66	0.00	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.99	5.67	2.08	0.55	0.55	0.00	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	40.84	8.03	1.40	2.79	1.40	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	37.97	5.31	1.63	1.22	2.25	0.00	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.77	2.52	0.72	1.08	1.44	0.00	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.28	3.83	0.93	0.52	0.93	0.10	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.98	2.74	1.14	1.14	3.65	0.68	0.23	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	36.08	2.94	2.52	2.94	1.68	0.00	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.34	4.63	1.79	0.15	1.49	0.00	0.15	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	30.11	2.98	1.93	0.35	0.44	0.09	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.08	4.79	1.84	0.74	1.84	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.32	4.86	1.43	0.86	0.86	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	67.78	13.47	2.11	82.94	1.68	0.84	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	35.62	11.42	3.20	7.31	0.91	1.37	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.74	8.70	1.79	1.79	1.79	1.53	2.05	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.17	7.07	2.09	3.14	0.79	0.79	1.05	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	42.52	11.09	3.39	3.08	1.23	0.00	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.36	10.12	1.41	3.53	1.88	0.94	2.12	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	35.54	8.80	1.69	4.06	1.35	1.02	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.08	9.43	1.57	5.11	0.39	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.58	7.88	1.39	6.49	0.93	0.00	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	39.80	12.11	2.88	2.60	2.60	2.31	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.02	10.04	1.34	3.79	0.22	1.34	1.56	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.93	9.37	1.68	4.57	2.16	1.20	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.73	9.53	1.47	2.93	0.00	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.21	12.08	2.01	3.02	1.34	1.68	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	32.34	6.14	2.46	4.50	1.64	1.23	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.08	8.59	1.72	4.30	2.58	3.44	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	19.14	10.94	2.73	2.73	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.83	12.02	1.30	2.27	0.65	1.30	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	14.55	1.45	1.45	2.91	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	33.58	19.19	2.13	1.07	2.13	2.13	1.60	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	35.16	10.63	4.91	4.91	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	25.27	13.61	2.33	1.94	1.17	1.55	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	16.79	4.20	2.10	4.20	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	9.93	0.99	2.98	1.99	0.00	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	4.77	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	30.83	14.82	2.37	4.15	1.19	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	30.46	10.97	3.66	2.44	0.00	1.22	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	27.24	13.93	2.53	1.90	1.27	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.42	7.24	1.03	0.34	1.38	0.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	4.30	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	7.98	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	3.67	0.81	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	3.18	2.38	0.00	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	6.48	1.18	0.00	0.00	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.40	6.55	0.62	0.00	0.62	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	8.02	2.67	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	21.29	17.74	1.18	0.00	0.00	0.00	0.00	7.10
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	12.84	5.14	2.57	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	22.72	0.69	1.38	0.00	0.00	0.00	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.26	12.86	0.99	0.00	0.00	0.00	0.00	3.96
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	11.22	1.12	1.12	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	33.71	15.90	0.00	0.64	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	25.39	5.64	0.00	0.00	0.00	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	10.90	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	7.60	0.00	0.00	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.17	4.25	0.00	0.00	0.00	0.00	0.00	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	18.08	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	4.94	2.47	0.82	0.00	0.00	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	16.87	10.12	1.59	0.00	0.20	0.00	0.00	2.78
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.85	9.09	1.95	0.32	0.32	0.00	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	12.22	0.00	0.00	0.00	0.00	0.00	4.07
mesodermal tumor cell line:HIRS-BM	10696-109G3	11.61	2.32	0.77	13.15	1.55	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	43.23	5.91	4.02	1.18	2.83	0.71	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.70	4.17	3.01	4.17	0.93	4.87	8.34	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.73	2.26	1.03	3.08	2.06	2.26	1.64	0.00
mesothelioma cell line:Mero-25	10850-111F4	34.72	3.86	1.13	1.82	0.00	2.04	2.27	0.00
mesothelioma cell line:Mero-41	10851-111F5	33.25	7.58	1.47	0.73	1.22	0.73	0.73	0.24
mesothelioma cell line:Mero-48a	10852-111F6	23.03	5.09	1.99	1.33	1.55	0.66	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	23.39	7.10	1.05	0.79	0.79	0.26	2.37	0.26
mesothelioma cell line:Mero-83	10854-111F8	22.30	2.55	1.36	2.72	1.36	0.34	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	38.17	4.04	0.76	0.25	0.51	0.25	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	35.82	5.59	3.31	2.07	1.45	2.28	1.86	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	54.50	12.75	2.98	1.16	0.99	1.33	0.99	0.50
mesothelioma cell line:NCI-H226	10846-111E9	26.79	6.70	1.63	1.99	1.27	1.99	1.99	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	27.50	9.05	2.05	1.71	1.88	0.34	0.34	1.02
mesothelioma cell line:NCI-H28	10845-111E8	23.92	3.31	1.53	0.25	0.25	0.51	0.25	1.02
mesothelioma cell line:No36	10857-111G2	13.70	1.96	1.30	0.00	0.98	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	18.70	5.15	0.54	3.25	0.27	0.00	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	13.82	0.96	0.38	0.19	0.00	0.19	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	18.68	2.44	0.73	0.49	0.00	0.00	0.12	0.49
migratory langerhans cells, donor3	11903-125F4	33.92	4.31	2.15	0.36	0.36	0.18	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.14	5.88	2.29	0.33	1.31	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	38.36	5.51	2.33	0.64	0.64	0.00	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	53.67	16.82	6.45	7.83	1.61	2.30	2.53	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.74	6.85	2.09	0.57	0.00	0.19	0.19	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	29.94	5.91	1.11	0.18	0.00	0.00	0.00	0.18
myeloma cell line:PCM6	10474-106I6	28.07	12.85	4.94	2.17	0.00	0.20	0.20	2.97
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.60	7.61	1.52	0.51	1.01	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.07	10.98	4.32	1.57	0.78	0.20	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.22	13.93	3.45	2.45	1.89	1.89	3.45	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	43.09	12.28	2.35	2.57	2.87	3.46	3.31	0.37
nasal epithelial cells, donor2	12227-129F4	34.22	8.83	2.76	1.10	1.10	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	40.72	3.91	2.07	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	70.91	4.49	3.37	0.19	0.00	0.37	0.19	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	39.86	1.48	1.48	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	46.22	0.56	1.30	0.00	0.00	0.00	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.61	0.47	0.47	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.92	1.58	0.32	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	77.89	3.62	6.04	0.00	0.00	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.14	3.81	1.27	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	34.87	7.45	1.60	2.40	0.00	0.53	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	27.23	5.92	3.04	1.01	0.17	0.17	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	80.85	11.21	6.40	0.00	0.00	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.12	4.81	2.56	1.92	1.28	1.92	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	22.33	6.83	0.26	0.79	1.31	0.79	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	4.69	1.22	0.00	0.00	0.00	0.09	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	11.81	1.34	0.54	0.27	0.00	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	6.91	3.64	0.00	0.00	1.09	0.00	0.00	1.46
occipital lobe, adult, donor1	10076-102A4	5.77	1.84	0.52	0.00	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	72.52	10.30	6.01	0.00	0.00	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	4.34	1.26	0.08	0.00	0.00	0.00	0.00	0.08
olfactory region, adult	10195-103E6	5.16	0.57	0.38	0.00	0.00	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	0.00	2.00	0.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.99	9.11	2.28	0.46	2.73	1.71	1.25	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	47.54	16.49	5.08	0.00	0.14	0.00	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.09	10.33	2.03	0.68	0.85	1.52	1.86	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	45.97	12.71	2.89	0.23	0.23	0.23	0.00	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	19.40	4.12	1.47	2.65	0.59	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	49.52	7.47	8.41	0.00	2.80	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	21.63	5.30	1.48	0.42	0.21	0.21	0.00	0.42
ovary, adult, pool1	10020-101D2	12.23	0.96	0.17	0.09	0.00	0.00	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	27.13	4.77	2.02	0.37	0.18	0.18	0.00	0.18
pancreas, adult, donor1	10049-101G4	31.04	12.23	4.70	26.34	0.00	0.00	0.94	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.98	19.01	1.12	0.00	0.00	0.28	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	32.88	10.73	1.87	8.52	1.02	4.09	6.98	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.96	3.97	1.82	17.22	0.66	3.15	5.46	0.66
paracentral gyrus, adult, pool1	10035-101E8	4.39	1.74	0.09	0.09	0.00	0.00	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	2.20	0.73	0.73	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	0.94	2.82	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	6.27	0.29	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	4.14	1.50	0.18	0.09	0.00	0.00	0.00	0.18
parietal lobe, fetal, donor1	10072-101I9	49.46	5.82	1.94	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.98	2.62	0.75	0.00	0.00	0.00	0.00	1.50
parotid gland, adult	10199-103F1	20.35	6.17	0.00	4.32	0.00	0.00	0.00	2.47
penis, adult	10200-103F2	6.98	4.83	1.07	3.76	0.00	0.00	0.00	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.94	3.53	0.00	0.00	0.00	0.00	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.97	18.36	3.50	1.02	0.15	0.15	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	2.58	1.94	0.00	0.65	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	8.88	1.18	0.59	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	2.51	1.88	0.63	0.63	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	6.07	1.01	0.00	1.01	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	4.69	1.04	0.00	0.52	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	8.51	3.40	0.00	1.70	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	23.54	5.48	1.18	0.11	1.29	6.34	1.72	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	28.87	5.69	0.93	0.00	0.00	0.00	0.00	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.85	1.09	1.40	0.93	0.16	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	4.65	0.95	0.17	0.09	0.00	0.00	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	4.71	1.57	0.00	0.00	0.09	0.00	0.00	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	83.66	18.82	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	11.02	11.02	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	35.21	0.00	0.00	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	42.53	9.32	3.50	0.87	1.89	0.87	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	65.70	17.79	11.07	2.54	1.63	0.54	1.09	1.63
prostate, adult, pool1	10022-101D4	9.79	1.45	0.54	0.63	0.00	0.00	0.00	0.00
putamen, adult, donor10196	10176-103C5	4.01	1.18	0.47	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	15.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	2.17	1.69	0.00	0.24	0.00	0.00	0.00	0.24
putamen, newborn, donor10223	10365-105F5	3.00	0.75	0.00	0.00	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	32.58	10.18	2.91	0.00	0.58	1.45	0.00	1.16
rectum, fetal, donor1	10067-101I4	9.74	2.78	1.39	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	26.29	5.94	1.70	0.85	0.64	0.21	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.57	22.37	0.83	0.00	2.49	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	6.16	0.80	0.30	0.10	0.00	0.00	0.00	0.00
retinoblastoma cell line:Y79	10475-106I7	37.93	9.87	2.60	0.00	0.00	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	42.42	9.10	5.04	0.98	1.11	0.61	0.61	3.07
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	109.67	20.53	10.40	0.56	0.00	0.00	0.28	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	1.52	2.27	1.52	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	16.67	4.21	1.46	0.16	0.97	0.65	0.16	0.16
salivary acinar cells, donor2	11772-123I8	17.21	9.78	0.55	0.96	0.83	0.69	0.55	0.41
salivary acinar cells, donor3	11773-123I9	12.58	6.62	1.32	0.66	0.66	1.32	0.66	0.00
salivary gland, adult, pool1	10093-102C3	12.58	2.86	0.57	4.00	0.00	0.00	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.00	3.29	1.10	0.08	4.22	0.08	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	14.46	2.82	0.82	0.00	2.70	0.35	0.12	0.71
seminal vesicle, adult	10201-103F3	8.47	1.59	0.53	3.17	0.53	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.62	6.32	1.46	1.21	1.94	2.43	2.43	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.25	1.76	1.01	0.75	0.25	0.50	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	63.22	4.01	2.01	3.01	4.01	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.64	1.61	0.94	0.00	0.27	0.67	0.81	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	15.25	4.20	0.88	4.64	1.44	0.44	3.09	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.87	5.55	2.84	3.35	1.68	0.90	2.71	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	10.64	20.57	0.00	2.84	0.00	0.00	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	25.31	13.79	1.32	8.28	0.24	0.36	0.12	2.04
skeletal muscle, fetal, donor1	10066-101I3	20.10	9.05	3.02	1.01	0.00	1.01	0.00	2.01
skin, adult, donor1	10074-102A2	0.00	6.79	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	20.83	3.16	0.63	1.26	0.63	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	34.69	7.00	3.00	0.00	0.00	0.33	0.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	33.73	0.95	0.95	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	72.28	4.63	1.54	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	31.15	5.44	3.13	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.02	0.80	0.97	0.00	0.00	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	70.17	28.98	8.28	8.50	0.65	0.00	0.00	3.92
small intestine, adult, pool1	10024-101D6	5.37	0.96	0.96	0.24	0.48	0.00	0.12	12.18
small intestine, fetal, donor1	10064-101I1	7.13	0.98	0.74	0.00	0.00	0.25	0.00	2.95
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.08	17.44	0.51	4.62	0.51	0.00	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	9.05	1.03	0.52	0.00	0.26	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	50.92	13.13	4.29	5.09	1.07	0.00	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	2.75	0.92	0.69	0.00	0.00	0.00	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	10.25	1.97	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	4.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	15.25	4.88	1.22	0.00	0.00	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	8.27	0.92	0.00	1.38	0.46	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.98	8.07	2.84	2.39	0.90	0.90	0.30	0.00
spleen, adult, pool1	10025-101D7	17.07	0.99	0.77	1.32	0.00	0.00	0.00	0.44
spleen, fetal, pool1	10044-101F8	17.08	1.27	0.72	0.87	0.00	0.00	0.00	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.91	1.97	0.83	0.41	0.21	0.00	0.31	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.33	5.89	2.47	0.19	0.00	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.66	4.89	0.00	0.00	1.05	2.10	2.80	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	50.43	12.51	3.52	0.78	3.91	0.78	1.56	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	57.86	19.25	4.95	2.36	3.60	0.23	0.68	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	20.33	1.27	0.00	0.00	0.00	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.46	7.19	1.69	0.00	1.27	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	20.29	9.61	0.00	0.00	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	14.24	10.82	3.99	7.41	0.57	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	8.10	1.87	0.42	0.21	0.00	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	4.66	2.59	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	5.65	3.53	0.71	1.41	0.71	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	65.34	4.13	3.21	0.00	0.00	0.00	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	5.76	1.78	0.00	0.17	0.17	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	118.24	7.83	0.71	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	102.85	7.91	1.32	0.00	0.44	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	38.40	6.63	1.40	3.84	1.75	1.40	0.70	0.35
tenocyte, donor2	11765-123I1	24.03	5.72	0.76	4.58	2.29	0.76	0.38	0.38
tenocyte, donor3	11768-123I4	35.21	7.04	2.22	9.64	5.56	2.97	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	29.57	5.95	1.87	0.00	0.17	0.17	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	46.55	1.39	2.00	0.00	0.00	0.15	0.00	0.46
teratocarcinoma cell line:PA-1	10807-111A6	45.10	1.24	2.79	0.00	0.00	0.31	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	46.34	3.43	2.29	0.00	0.13	5.97	3.94	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	28.74	1.89	1.13	0.00	0.00	0.38	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.56	4.14	0.76	0.00	0.22	9.92	3.49	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.36	0.33	1.63	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	11.17	0.64	0.43	0.11	0.00	0.00	0.00	0.00
testis, adult, pool2	10096-102C6	12.63	1.35	0.00	0.00	0.00	0.45	0.00	0.00
thalamus - adult, donor10196	10168-103B6	2.21	2.21	0.00	0.00	0.00	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	10.00	0.63	0.63	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	3.08	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.60	1.32	0.66	0.00	0.00	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	7.48	1.15	0.58	1.15	0.00	0.00	0.00	1.15
throat, adult	10209-103G2	13.48	7.99	1.50	2.00	0.75	0.00	0.50	3.25
throat, fetal, donor1	10061-101H7	12.80	1.52	1.22	1.22	0.00	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	76.31	5.76	1.79	0.00	0.00	0.00	0.00	0.60
thymus, adult, pool1	10027-101D9	26.54	2.29	1.29	1.19	0.00	0.20	0.00	1.39
thymus, fetal, pool1	10043-101F7	13.30	0.83	0.31	0.94	0.21	0.10	0.00	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	46.00	5.98	4.92	0.53	2.79	0.93	0.66	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	77.95	11.18	4.75	2.51	2.79	1.12	2.10	0.42
thyroid, adult, pool1	10028-101E1	14.84	2.43	0.56	0.19	0.00	0.00	0.09	0.09
thyroid, fetal, donor1	10060-101H6	8.70	4.48	0.79	0.26	0.00	0.00	0.00	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	9.24	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	20.47	10.00	1.16	1.63	0.47	0.47	0.23	4.88
tongue, fetal, donor1	10059-101H5	19.31	5.52	1.18	1.58	0.00	0.39	0.00	4.34
tonsil, adult, pool1	10047-101G2	20.84	3.81	1.00	2.10	0.80	0.30	0.20	0.50
trachea, adult, pool1	10029-101E2	15.13	3.27	1.15	0.82	0.25	0.25	0.16	0.25
trachea, fetal, donor1	10058-101H4	11.54	4.62	0.00	0.77	0.38	0.00	0.00	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.07	11.69	2.48	2.83	1.42	1.06	0.71	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	41.13	7.50	4.66	1.11	0.00	0.30	0.81	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.49	5.33	2.35	0.31	1.88	0.31	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	34.25	7.61	1.90	1.90	1.90	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.12	8.13	1.69	4.57	2.20	3.22	5.93	0.59
umbilical cord, fetal, donor1	10057-101H3	16.69	8.35	0.00	0.00	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	3.75	1.37	0.00	0.00	0.17	0.00	0.00	0.00
uterus, fetal, donor1	10055-101H1	19.97	5.12	1.02	0.51	1.02	0.00	0.00	0.00
vagina, adult	10204-103F6	10.34	1.94	0.65	1.29	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	7.45	1.75	0.88	1.10	0.22	0.00	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	25.90	4.54	1.34	0.80	0.00	0.27	0.53	0.53